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Prolactin is a pituitary hormone whose main functions are mammary development, 
activation of lactation and cell proliferation. The prolactin receptor is overexpressed in 
many types of cancer tissues, making prolactin a molecule of pharmacological interest. 
The nature of the interaction between prolactin and the prolactin receptor has been the 
subject of several studies, but results have been ambiguous. It has been shown that 
prolactin acts through the sequential association of two prolactin receptors, but the 
underlying nature of this association is unclear. Different binding affinities have been 
suggested for the interaction, an allosteric effect driven by entropy loss proposed, and 
most studies have been performed with truncated or altered prolactin variants, putting 
the relevance of the observed properties into question. In an effort to clarify the lingering 
questions we studied the formation of prolactin-prolactin receptor complexes in solution 
using NMR and the wild type of prolactin and the extracellular domain of the prolactin 
receptor. 
We show that wild type prolactin is capable of forming both the binary and ternary 
complex with the extracellular domain of the prolactin receptor in solution, and we 
determine which of the proposed binding affinities apply to wild type prolactin. We 
demonstrate that the properties observed for the truncated and altered prolactin variants 
are shared by wild type prolactin. Lastly we rule out conformational entropy as the 
driving force of the proposed allosteric effect.
Janus Vang – University of Connecticut, 2013 
Furthermore, metal binding by members of the growth hormone family has been 
suggested to play a role in facilitating reversible packing in secretory granules.  
To unambiguously determine the metal binding site(s) on prolactin, we performed 
paramagnetic metal titration and chelation experiments on recombinant prolactin 
monitored by NMR relaxation. Cu2+ mediated paramagnetic relaxation enhancements 
(PRE) identify two metal binding sites on prolactin. The relative orientation of the two 
distinct metal binding sites, together with aggregation studies of hPRL mutants at 
biologically relevant pH values, enable us to propose a mechanism for metal-induced 
aggregation entailing intermolecular bridging between the metal binding sites. The 
proposed mechanism supports the previously suggested role of metal coordination in 
reversible hPRL packaging in secretory granules. 
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1 
1 Background 
Kaj Ulrik Linderstrøm-Lang observed one of the earliest indications of structural 
properties of proteins in the early 1950’s: NH hydrogen exchange. While testing Linus 
Pauling’s newly formed ideas of α-helices and β-sheets stabilized by hydrogen bonds1, 
Linderstrøm-Lang observed that peptide group NH hydrogens engage in continual 
exchange with the hydrogens of the solvent. After developing a method to measure H-D 
exchange that included cryosublimation and a density-gradient technique, he studied the 
phenomenon in many different proteins2–7 and even with a low resolution (compared to 
modern techniques) he was ultimately able to connect NH hydrogen exchange to protein 
dynamics and energetics8. Linderstrøm-Lang’s equations still form the theoretical basis 
of modern hydrogen exchange. Thus the dynamic nature of protein structures in solution 
has been known since before the first protein structure was solved, but the underlying 
mechanisms and their influence on protein function were enigmatic. 
X-ray crystallography allowed scientific pioneers to determine the crystal structures of 
proteins in the 1960’s and 70’s. The high quality and resolution of crystal protein 
structures has made the concept of a single, static “folded protein state” alluring, but the 
limitations of this view are made clear by the very same technique. The classic example 
of this is hemoglobin. Max Ferdinand Perutz received the Nobel prize for utilizing x-ray 
crystallography to determine the structure of hemoglobin in different states of 
oxygenation, but he noted the absence of an entrance to the heme pocket large enough 
to accommodate an oxygen atom9. He mused that the explanation probably was a 
dynamic structure, but since crystal structures are static, he was reduced to guessing9.  
In 1985 a major step was taken towards understanding structural dynamics in proteins 
as NMR techniques capable of handling the large sizes of proteins were utilized to 
 
 
2 
determine the first solution structure of a protein10,11. In early NMR structures highly 
dynamic parts of the protein were just seen as poorly defined areas, but NMR relaxation 
experiments analyzed with the Model-Free approach12,13 demonstrated that one of 
NMR’s unique advantages is its capability to determine structural dynamics both 
qualitatively and quantitatively. NMR is currently being combined with powerful 
computational tools like molecular dynamic simulations (MD) to study how structural 
dynamics contribute to enzymatic rate acceleration and specificity. The combination of 
NMR and MD enables researchers to follow the enzyme’s structural configuration on a 
nanosecond-to-millisecond scale. The conclusion is that larger scale protein movements 
are not completely random, but follow distinct pathways to create positioning that allows 
efficient catalysis14,15. 
This thesis utilizes NMR spectroscopy in order to obtain a comprehensive 
understanding of the interaction of prolactin (PRL) with the prolactin receptor (PRLR) 
and metal ions that includes the influences of the dynamic properties of the molecular 
structure of PRL. 
2 Theory 
This thesis utilizes NMR relaxation to measure the structural dynamics of proteins. 
This chapter is a brief introduction to the theory behind this technique, related 
phenomena and the Model Free approach to analyzing the NMR relaxation data. 
NMR is a quantum mechanical phenomenon, however a semi-classical description 
suffices for explaining many properties. The following description employs the semi-
classical treatment. For a more in depth treatment, see Abragam 196116. 
 
 
3 
2.1 Nuclear spin relaxation 
Nuclei with spin generate a magnetic field, sometimes called the magnetic moment (µ) 
(Fig. 1). When nuclei with spin ½ are subjected to an external magnetic field B0, the 
spins will inhabit two discrete energy states, one high-energy state (P2) and one low 
energy state (P1). Depending on the sign of the spin’s g-factor the magnetic moment of 
these states will align with or against B0. In the case of protons, P2 will align against B0 
and P1 will align with B0 (Fig. 2).  
The magnetic moment (µ) isn’t parallel with B0, it is precessing around B0 (Fig. 3) with a 
rate called the Larmor frequency (in radians/time): 𝜔! = 𝛾𝐵!                     1𝑎  
(in Hz): 
𝜈! = 𝛾𝐵!2𝜋                      1𝑏  
γ is the gyromagnetic ratio of the nucleus, a property determined by the ratio of the 
magnetic moment to the angular momentum.  
The population difference ratio between the nuclear spin energy states in a system in 
equilibrium is given by: 𝑃!𝑃! = 𝑒!∆!!"                      2  
where ΔE is the energy difference between the nuclear spin energy states, k is the 
Boltzmann constant and T is the temperature in K. ΔE can be described using the 
Planck-Einstein equation (𝐸 = ℏ𝜈): 
∆𝐸 = ℏ𝜈! = ℎ𝛾𝐵!2𝜋                      3  
At equilibrium there will thus be a small population excess in the lower energy state, 
resulting in a small net magnetization (M0) aligned with B0. To get an idea of the size of 
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this population excess, we can look at protons in a 800 MHz magnet at 25°C, which 
would produce a population difference ratio of 0.999872, meaning that for every 
1000000 spins in the upper energy state there are 1000128 spins in the lower energy 
state, in other words only 128 out of 2000000 spins contribute to M0. The small 
population difference is one of the inherent reasons for the low sensitivity of NMR. 
Absorbance of external radiation at ω0 causes a transition of spins from the low energy 
state to the high-energy state, resulting in an excited sample with an increased spin 
population in P2. The return to the equilibrium population levels is called nuclear spin 
relaxation or NMR relaxation16. 
2.1.1 Bloch	  equations	  
The Bloch equations are a phenomenological approach for describing single spin 
system NMR relaxation. The equations describe the rate of return of magnetization to 
the equilibrium state after excitation without going into the underlying mechanisms17.  𝑑𝑀! 𝑡𝑑𝑡 = 𝛾 𝑀 𝑡 ×𝐵 𝑡 ! − 𝑅! 𝑀! 𝑡 −𝑀!                    4  𝑑𝑀! 𝑡𝑑𝑡 = 𝑀 𝑡 ×𝐵 𝑡 ! − 𝑅!𝑀! 𝑡                                                    5  𝑑𝑀! !𝑑𝑡 = 𝛾 𝑀 𝑡 ×𝐵 𝑡 ! − 𝑅!𝑀! 𝑡                                                  6  
Where M is the vector of the magnetization projected on the xyz axis, M0 is the 
equilibrium magnetization, B is the applied magnetic field along the z-axis and R1 and R2 
are the rates at which the relaxation occur17.  
R1 refers to the rate of the return of magnetization to equilibrium along the applied 
magnetic field B0 after excitation. R1 is also called longitudinal relaxation (because B0 is 
oriented along the z-axis) or spin-lattice relaxation, since transfer of spins from P2 to P1 
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involves emitting energy from the spins to the surroundings (the lattice in solid-state 
NMR). The development of Mz can be written as  
𝑀! 𝑡 = 𝑀! − 𝑀! −𝑀! 0 𝑒!!!!                      7  
where T1=1/R1. When Mz(0) is 0, Mz(t) can be written as: 
𝑀! 𝑡 = 𝑀! 1 − 𝑒!!!!                      8  
T1 is therefore the time it takes Mz to recover to (1 − 𝑒!! = 0.63) 63% of its original value, 
and thus T1 can be used to determine how much time is needed for the system to relax, 
i.e. how much time is needed between experiments.  
R2 refers to the rate of coherence loss of the x,y magnetization. R2 is thus called the 
transverse (x,y plane is transverse to the z axis) or spin-spin relaxation, since R2 
relaxation transfers energy between spins (no net loss of energy to the surroundings), 
but lowering the lifetime of the spins in the excited state. Mxy can be written as: 
𝑀!" 𝑡 = 𝑀!" 0 𝑒!!!!                      9  
T2 is therefore the time needed for Mxy to be reduced to 37% of its value just after 
induction.  
Heisenberg’s uncertainty principle (equation 10) states that the uncertainty in energy 
(ΔE) is inversely proportional to the lifetime of the spins in the excited state (Δt). 
∆𝐸∆𝑡 = ℎ2𝜋                      10  
Since the average lifetime of the excited spin state can’t be longer than T1, linewidths 
can’t be smaller than 1/T1. T2 is smaller or equal to T1 depending on the size of the 
molecule and the viscosity of the sample (Fig. 4), meaning that the true linewidth of NMR 
signals are derived from 1/T218.  
 
 
6 
2.1.2 Solomon	  equations	  
One way of looking at longitudinal or spin-lattice relaxation is to observe the transition 
rates of the spins between energy levels. Figure 5 shows a system where two spins 
(I+S) are coupled by dipole-dipole (DD) interactions, and where the transition rates are 
marked WI, WS, W0 and W2. WI and WS are single spin transitions, W0 is a process 
where one spin transitions from high to low, while the other transitions from low to high 
(a zero quantum transition), and WS is a process where both spins transition the same 
way (double quantum transition). 
In a system like this, the population of the αα energy level (Pαα) can be described by a 
differential equation of the transition rates:  𝑑𝑃!!𝑑𝑡 = − 𝑊! +𝑊! +𝑊! 𝑃!! +𝑊!𝑃!" +𝑊!𝑃!" +𝑊!𝑃!! + 𝐾                     11  
K is a constant that drives the population back to equilibrium level (𝑃!!! ). K can be found 
by setting the left side of the equation to 0: 𝐾 = 𝑊! +𝑊!+𝑊! 𝑃!!! −𝑊!𝑃!"! −𝑊!𝑃!"! +𝑊!𝑃!!!                      12  
The difference between the population of the spin energy level and the equilibrium 
population ∆𝑃!! = 𝑃!! − 𝑃!!!  can therefore be written as: 𝑑∆𝑃!!𝑑𝑡 = − 𝑊! +𝑊!+𝑊! ∆𝑃!! +𝑊!∆𝑃!" +𝑊!∆𝑃!" +𝑊!∆𝑃!!                      13  
The populations of the other energy levels can be described in the same way: 𝑑∆𝑃!"𝑑𝑡 = − 𝑊!+𝑊!+𝑊! ∆𝑃!" +𝑊!∆𝑃!! +𝑊!∆𝑃!! +𝑊!∆𝑃!"                      14  𝑑∆𝑃!"𝑑𝑡 = − 𝑊!+𝑊!+𝑊! ∆𝑃!" +𝑊!∆𝑃!! +𝑊!∆𝑃!! +𝑊!∆𝑃!"                      15  𝑑∆𝑃!!𝑑𝑡 = − 𝑊!+𝑊!+𝑊! ∆𝑃!! +𝑊!∆𝑃!" +𝑊!∆𝑃!" +𝑊!∆𝑃!!                      16  
The operator for the magnetization of spin I in the z-axis (Iz) can be written as 
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𝐼! = 𝑃!! + 𝑃!" − 𝑃!" − 𝑃!!                      17  
and Sz can similarly be written as  𝑆! = 𝑃!! + 𝑃!" − 𝑃!" − 𝑃!!                      18  
Thus the change in Iz and Sz can be written as 𝑑∆𝐼! 𝑡𝑑𝑡 = − 𝑊!+2𝑊!+𝑊! ∆𝐼! 𝑡 − 𝑊! −𝑊! ∆𝑆! 𝑡                      19  𝑑∆𝑆! 𝑡𝑑𝑡 = − 𝑊! + 2𝑊!+𝑊! ∆𝑆! 𝑡 − 𝑊!−𝑊! ∆𝐼! 𝑡                      20  
If we set (W0+2WI+W2)  = ρI, (W0+2WS+W2) = ρS and (W2-W0) = σIS, the Solomon 
equations can be written as 𝑑∆𝐼! 𝑡𝑑𝑡 = −𝜌!∆𝐼! 𝑡 − 𝜎!"∆𝑆! 𝑡                    21  𝑑∆𝑆! 𝑡𝑑𝑡 = −𝜌!∆𝑆! − 𝜎!"∆𝐼! 𝑡                              22  
where ρI and ρS are the equivalent of the Bloch longitudinal or spin-lattice relaxation rate 
R1 and σIS is the cross relaxation rate, which allow magnetization transfers between 
spins in the presence DD interactions18. The W2 part of the cross relaxation rate is 
stimulated at magnetic fields oscillating at frequencies around the sum of the Larmor 
frequencies of the involved spins, while the W0 part of the cross relaxation rate is 
stimulated at magnetic fields oscillating at frequencies around the difference of the 
Larmor frequencies of the involved spins. 
The Solomon equations are key to understanding the Nuclear Overhauser Effect 
(NOE), which is magnetization transfer through cross relaxation from one spin 
population to another. 
When a spin I is saturated, WI is stimulated so that the population difference between 
the high and low energy state of spin I are equalized. The only way for spin I to return to 
equilibrium is via cross relaxation, W0 and W2, but each of these transitions will result in 
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a spin transition for both spin I and spin S. Flipping a spin I β to α through Wo pulls a spin 
S α to β, reducing the S population difference, and thus the S signal intensity. Flipping a 
spin I β to α through W2 pulls a spin S β to α, increasing the S population difference, and 
thus the S signal intensity. 
When the overall tumbling rate of the molecule (τm) is faster than the Larmor frequency 
of the spins involved, W2 dominates the cross relaxation rate, and if τc is slower than the 
Larmor frequency of the spins involved, W0 dominates the cross relaxation rate. 
The direct coupling of NOE to molecular motion (Fig. 6) makes the steady-state NOE 
difference experiment one of the classic NMR relaxation experiments, the two other 
being T1 and T2 measurements. The steady-state NOE difference experiment consists of 
two recorded spectra, one where spin S is saturated long enough to facilitate a NOE on 
spin I, and one where spin S isn’t saturated. In the saturation experiment the resulting 
intensity of spin I is proportional to a steady-state value 𝐼!!!, and in the unsaturated 
experiment the intensity of I is proportional to𝐼!!. During saturation !∆!!!" = 0 and 𝑆! = 0, 
and from the Solomon equations it can be derived that 𝑑𝐼!!!𝑑𝑡 = −𝜌! 𝐼!!! − 𝐼!! + 𝜎!"!"#𝑆!!                       23  𝐼!!!𝐼!! = 1 + 𝜎!"!"#𝑆!!𝜌!𝐼!!                                                                      24  𝐼!!!𝐼!! = 1 + 𝜎!"!"#𝛾!𝜌!𝛾! = 1 + 𝜂!"                                 25  
where ηIS is called the steady-state NOE enhancement1818. 
2.1.3 Nuclear	  spin	  relaxation	  and	  molecular	  motion	  
 
The per time unit probability (W) of a spontaneous transition of an isolated dipole from 
P2 to P1, accompanied by the emission of a photon, is given by16: 
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𝑊 = 2ℏ𝛾!𝜔!3𝑐!                      26  
where c is the speed of light, ℏ  is Planck’s constant divided by 2π and ω is the Larmor 
frequency of the spin. From this equation it can be gathered that W for a proton with the 
Larmor frequency of 500 MHz is 10-21 s-1, making spontaneous emission irrelevant for 
NMR relaxation. Transition between nuclear spin energy states are induced by 
oscillating magnetic fields at ω (the MHz range), and the magnetic fields necessary for 
NMR relaxation are provided by random molecular motions in the ps-ns time scale. The 
molecular motions in the right time scale are overall molecular tumbling (ns time scale) 
and site specific internal motion (ps time scale) and the two major mechanisms by which 
these molecular motions creates oscillating magnetic fields in the MHz range are dipole-
dipole (DD) interaction and chemical shift anisotropy (CSA). Combined with chemical 
exchange these mechanisms constitute the major contributors to NMR relaxation.   
2.1.3.1 Dipole-­‐dipole	  interaction	  
 
Through-space interactions between the magnetic dipole moments of a pair of nuclear 
spins affect the magnetic field experienced by each spin in a distance and orientation 
dependent manner. Molecular motions alter both internuclear distance and orientation, 
so molecular motions in the ps-ns time scale will cause DD interactions to create the 
oscillating magnetic fields in the MHz range which allows NMR relaxation19. DD 
interactions are arguably the most important mechanism causing NMR relaxation. 
2.1.3.2 Chemical	  shift	  anisotropy	  
The magnitude of local magnetic fields (the chemical shift) depends on the orientation 
of the bond vector of the involved nuclear spins compared to the applied magnetic field 
B0. Molecular motion will vary the orientation of said bond vector, and if they are on the 
ps-ns time scale, CSA will result in oscillating magnetic fields in the MHz range. 
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2.1.3.3 Chemical	  exchange	  
Although the time scale of chemical exchange is too slow to generate oscillating 
magnetic fields in the MHz range (µs to ms), it still contributes to the dephasing of the 
transverse magnetization and thus to R2 by altering the nuclear spin precession 
frequency (ω). Thus R2 has a contribution Rex from chemical exchange. 
 
In order to quantitatively relate the NMR relaxation parameters R1, R2 and NOE to the 
oscillating magnetic fields caused by molecular motion it is necessary to quantify said 
molecular motion. To this end an orientation correlation function C(t) is employed, which 
describes the molecular motion as the time dependent reorientation of bond vectors. C(t) 
is the dot product of the bond vector (𝜇) at time 0 and a later time t: 𝐶 𝑡 = 𝑃! 𝜇 0 ∙ 𝜇 𝑡                      27  
where P2 is the second Legendre polynomial20. C(t) describes the “memory” of the 
original orientation of the bond vector as it is randomized over time and approaches 
zero. If applied to a completely rigid, spherical molecule with isotropic rotation, C(t) 
translates into an exponential decay, described by18: 
𝐶 𝑡 = 15 𝑒!!!!                      28  
where 𝜏! is the overall molecular rate of rotation (also called the overall molecular 
correlation time), that will reach a minimum in a time period reflected by the bond vectors 
reorientation (ns). The correlation function can be fourier transformed into the spectral 
density function J(ω), which quantifies the amplitude of molecular motion at any 
frequency (ω)18: 
𝐽 𝜔 = 25 𝜏!1 + 𝜔𝜏! !                      29  
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For an amide 15N nitrogen spin relaxation is dominated by DD interactions with the 
directly attached hydrogen, CSA and chemical exchange21, the relationship between the 
spectral density function and the three measurable NMR parameters R1, R2 and NOE 
can be written as16: 
𝑅! = 𝑑!"!4 𝐽 𝜔!−𝜔! + 3𝐽 𝜔! + 6 𝜔! + 𝜔! + 𝑐!! 𝐽 𝜔!                                    30  
𝑅! = 𝑑!"!8 4𝐽 0 + 𝐽 𝜔! − 𝜔! + 3𝐽 𝜔! + 6𝐽 𝜔! + 6𝐽 𝜔! + 𝜔!
+ 𝑐!!6 4𝐽 0 + 3𝐽 𝜔! + 𝑅!"                                                                                                      31  
𝑁𝑂𝐸 = 1 + 𝑑!"!4𝑅! 𝛾!𝛾! 6𝐽 𝜔! + 𝜔! − 𝐽 𝜔!−𝜔!                                                                              32  
Where ωH and ωN are the Larmor frequencies of 1H and 15N, γH and γN are the 
gyromagnetic ratios of 1H and 15N, dHN is the DD interaction of 1H and 15N and cN is the 
CSA interaction:  
𝑑!" = 𝜇!ℎ𝛾!𝛾!8𝜋! 𝑟!"!!                      33  
𝑐! = 𝜔!∆𝜎3                                                                    34  
where µ0 is the permeability of free space, h is Planck’s constant, , Δσ is the chemical 
shift anisotropy (CSA) for 15N and rNH is the average nitrogen-hydrogen bond length 
(1.02 Å)16,22. 
2.2 Model-free approach to molecular motion 
Molecular motion can be divided up into translational motion, tumbling and internal 
motion. Translational movement moves the molecule, but doesn’t change the local 
environment around the nuclei. This means that translational movement doesn’t affect 
the geometrical quantities in the nuclei’s magnetic moments, which renders it invisible to 
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NMR relaxation. Tumbling and internal motion thus accounts for all the motions that 
cause NMR relaxation. Giovanni Lipari and Attila Szabo proposed the model-free 
approach to describing molecular motion in 198212,13 which, as the name implies, does 
not rely on a physical model. Instead, assuming that overall motion and internal motion 
are completely independent of each other, the model free approach describes molecular 
motion using a correlation function Ct(t) consisting of the product of overall molecular 
motion Cm(t) and internal motion Ce(t)12,13: 𝐶! 𝑡 = 𝐶! 𝑡 𝐶! 𝑡                      35  
The overall molecular motion is the tumbling of the entire molecule, which is described 
by an exponentially decaying correlation function Cm(t), which can be described as the 
chance of finding the molecule in the same orientation over time. In case of isotropic 
motion, Cm(t) is equal to C(t) in equation (28), and in the case of anisotropic motion, 
Cm(t) is defined as: 
𝐶! 𝑡 = 15 𝐴𝑒!!!! + 1 − 𝐴 𝑒!!!!                      36  
where A (0 ≤ A ≤ 1) and 𝜏! and 𝜏! can be determined from relaxation data of nuclei 
attached to the backbone of the macromolecule13. The effective motion describes the 
internal motion of the individual residues in the molecule in a similar way, but this time 
there is an added factor, the generalized order parameter, S2. S2 is a value between 0 
and 1 that represents the spatial restrictions on the internal motion, with 0 representing 
unrestricted isotropic internal motion and 1 representing totally restricted internal 
motion21. The correlation function for the internal (or effective) motion (Ce(t)), which 
depends on both the rate of intramolecular motion and the spatial properties of the 
motion, can thus be described as: 
𝐶! 𝑡 = 𝑆! + 1 − 𝑆! 𝑒!!!!                      37  
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where t is time and τe is the effective correlation time. By combining the Cm and Ce 
correlation functions an expression that completely describes all motion in the molecule 
is made, which in case of isotropic movement is: 
𝐶! 𝑡 = 15 𝑆!𝑒!!!! + 1 − 𝑆! 𝑒!!!!                      38  
where τt is the total correlation time: 𝜏!!! = 𝜏!!! + 𝜏!!!                   39  
The Fourier transform of the correlation function is called the spectral density (J(ω)), 
which in the case of isotropic rotation can be written as:
 𝐽 𝜔 = 25 𝑆!𝜏!1 + 𝜔𝜏! ! + 1 − 𝑆! 𝜏!1 + 𝜔𝜏! !                      40  
For anisotropic movement, the spectral density function becomes: 
𝐽 𝜔 = 25 𝐴𝑆!𝜏!1 + 𝜔𝜏! ! + 1 − 𝐴 𝑆!𝜏!1 + 𝜔𝜏! ! + 𝐴 1 − 𝑆! 𝜏!,!1 + 𝜔𝜏!,! ! + 1 − 𝐴 1 − 𝑆! 𝜏!,!1 + 𝜔𝜏!,! !                      41  
where  𝜏!,!!! = 𝜏!!! + 𝜏!!!                     42𝑎  𝜏!,!!! = 𝜏!!! + 𝜏!!!                     42𝑏  
Lipari and Szabo showed that the model free approach holds true for τe << τm and τe in 
the extreme narrowing limit (ωτe << 1)12,13, which is the case if τe < 50-100 ps and τm > 1 
ns. If τe à 0 the second term of the equation for J(ω) can be ignored, and in the case of 
ωτe >> 1, S2 is set to 1, showing that relaxation rates are not affected by slow motions. 
For τe outside of the extreme narrowing limit it is possible to construct better 
approximations of the intramolecular motions by increasing the number of exponential 
terms. Clore et al.23 proposed a two-exponential correlation function given by: 
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𝐶! 𝑡 = 𝑆! + 𝐴!𝑒! !!! + 𝐴!𝑒! !!!                      43  
with S2 + Af + As = 1 and where τf and τs are correlation times for fast and slow time 
scales. When τf << τs, Ce(t) can be written as: 
𝐶! 𝑡 = 𝑆! + 1 − 𝑆!! 𝑒! !!! + 𝑆!! − 𝑆! 𝑒! !!!                      44  
where S2f is the order parameter for motions on the fast time scale. If it assumed that the 
fast motions are axially symmetric and independent of the slow motions, 𝑆! = 𝑆!!𝑆!!, 
which gives this expression for Ce: 
𝐶! 𝑡 = 𝑆!!𝑆!! + 1 − 𝑆!! 𝑒! !!! + 𝑆!! 1 − 𝑆!! 𝑒! !!!                      45  
In the case of isotropic overall rotation, the spectral density can be written as: 
𝐽 𝜔 = 25 𝑆!!𝑆!!𝜏!1 + 𝜔𝜏! ! + 1 − 𝑆!! 𝜏!,!1 + 𝜔𝜏!,! ! + 𝑆!! 1 − 𝑆!! 𝜏!,!1 + 𝜔𝜏!,! !                      46  
where 𝜏!,!!! = 𝜏!!! + 𝜏!!!                     47𝑎  𝜏!,!!! = 𝜏!!! + 𝜏!!!                     47𝑏  
 There are corresponding expressions for the spectral density if the overall rotation is 
anisotropic, which can be seen in Korzhnev et al. 200121. 
2.2.1 Model-­‐free	  analysis	  of	  NMR	  relaxation	  data	  
 
To analyze the NMR relaxation data, several analytical models for the spectral density 
with contributions from Cm(t), Ce(t) and an adjustable term Rex are constructed from 
equation (28, 36, 37 and 44). These analytical models for the spectral density allow the 
back calculation of theoretical values for the measurable NMR relaxation parameters R1, 
R2 and NOE using equation (30-32). Three models for Cm(t) are commonly used, one for 
isotropic tumbling, equation (28), and two for anisotropic tumbling, derived from equation 
 
 
15 
(36), one for axially symmetric anisotropic tumbling and one for fully anisotropic tubling21. 
The most used models for Cm(t) and Ce(t) can be seen in table 121,22: 
The model-free analysis fit the theoretical values derived from the models to the 
observed NMR relaxation data, followed by a goodness of fit analysis. The goodness of 
fit determines the optimal analytical model from which it is possible to extract the model-
free parameters. This approach is first applied to overall rotation of the molecule, since 
an accurate description of overall motion is important for the model selection concerning 
the internal motion. The internal motions analysis enables extraction of model-free 
parameters for each residue for which there are experimental data21.  
2.2.1.1 DASHA	  
DASHA is a software package designed to provide flexible tools for NMR dynamic 
analysis24 using the Lipari-Szabo “model-free” approach. It consists of two independent 
modules, DASHA and DIFFC. The DASHA module can extract “model-free” parameters 
using heteronuclear relaxation times, NOEs and their uncertainties as input. 
DASHA determines the fit of the theoretical data from analytical models to experimental 
data by non-linear minimization: 
𝜒! = 𝑉!!! 𝜁 − 𝑉!"# !Δ𝑉!"# !!!!!                      48  
where Vthe and Vexp are the theoretical and experimental values, and ΔVexp is the 
uncertainty of the experimental value. The adjustable variable ζ is held within user 
defined limits by adding a restrictive potential 𝑈 𝜁  to the penalty function24. 
Three different expressions for the internal motions correlation function, Ce, are used to 
analyze NMR relaxation data depending on the relation between the internal motion and 
the overall rotation (as described in the Model-free chapter).  
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1. If the internal motion is much faster (two orders of magnitude) than the overall 
rotation,  model 1 or 2 from table 1 are used. 
2. If the internal motion is between one to two orders of magnitude faster than the 
overall rotation, model 3 or 4 from table 1 are used. 
3. When the internal motion is on the same scale as the overall rotation, model 5 
from table 1 is used. 
DASHA can calculate the correlation function of the overall rotation Cm directly, using 
equation (28), if the rotational diffusion tensor of the molecule of interest is isotropic, 
deriving the overall correlation time τm from the T1/T2 ratio25. If the rotational diffusion 
tensor is anisotropic, the DIFFC module is needed. DIFFC can calculate the overall 
rotational correlation time and coefficients if the spatial structure of the molecule of 
interest is known, using the PDB data as input. DIFFC uses a beads model approach, 
where the molecule is considered a rigid body of points with a certain radius, also called 
beads, each representing a user defined atom reference. 
DASHA can then use the proposed overall correlation time from DIFFC to calculate the 
anisotropy factors:  the rotational diffusion tensor eigenvalues (D1, D2 and D3) and the 
Euler angles alpha, beta and gamma that describe the angles between the diffusion 
tensor and the PDB coordinate frame, enabling determination of the best model for 
overall tumbling of the molecule: isotropic, axially symmetric anisotropic or fully 
anisotropic24. 
2.3 Paramagnetic relaxation enhancement 
Paramagnetic relaxation enhancement (PRE) is the distance dependent effect of a 
paramagnetic substance upon the relaxation rates of nearby nuclei. PREs are caused by 
the magnetic DD interaction of the unpaired electrons of a paramagnetic center with a 
nucleus, causing an increase in relaxation rates. Because of the large magnetic moment 
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of unpaired electrons, PREs can, in contrast to NOEs, be observed through long 
distances (up to 35 Å)26. 
Using the Solomon-Bloembergen27,28 equations, PRE affected longitudinal (R1P) and 
transverse (R2P) relaxation of amide 15N can be expressed by29: 
𝑅!! = 215 𝜇!4𝜋 ! 𝛾!! 𝑔𝜇! !𝑆 𝑆 + 1𝑟! 3𝜏!1 + 𝜔!! 𝜏!! + 7𝜏!1 + 𝜔!!𝜏!! = 𝐾!𝑟!                      49  
𝑅!! = 115 𝜇!4𝜋 ! 𝛾!! 𝑔𝜇! !𝑆 𝑆 + 1𝑟! 4𝜏! + 3𝜏!1 + 𝜔!! 𝜏!! + 13𝜏!1 + 𝜔!!𝜏!! = 𝐾!𝑟! 50  
where 𝜇! is the vacuum permeability, 𝛾! is nitrogens gyromagnetic ratio, g is the ion 
factor for Cu2+, 𝜇! is the Bohr magneton, r is the nitrogen-metal distance, 𝜔! and 𝜔! are 
the Larmor frequencies of nitrogen and the electron spin, and the effective correlation 
time 𝜏! are given by the overall molecular rotation time 𝜏! and the electronic relaxation 
time 𝜏! by: 1𝜏! = 1𝜏! + 1𝜏!                      51  
3 Biophysical Investigation Reveals Details of 
Prolactin-Receptor Binding in Solution 
3.1 Introduction 
PRL is a pituitary hormone in the GH/PRL/PL family. It was first identified in 1928 by 
French researchers30, who showed that prolactin stimulates milk secretion in rabbits. 
In the 1970’s PRL bound to sepharose beads31 and auto radiographic methods (radio 
iodinated PRL)32,33 was used to establish that PRL binds to a specific receptor (PRLR) in 
mammary tissue. Shiu et al. isolated the membrane faction containing the receptor34, did 
extensive kinetic experiments on this preparation35, purified PRLR36 and developed a 
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specific antibody against PRLR37. This antibody selectively inhibited both binding and 
activity of PRL, but had no effect on other hormones (proving both that PRL mediates its 
effect through the PRLR, and the specificity of PRLR). Together these experiments show 
unequivocally that the action of PRL on mammary explants stringently requires the 
presence of PRLR. Since then PRL has been shown to exist in all vertebrates thus far 
examined and PRLR (a member of the class 1 cytokine receptor superfamily) has been 
found in a wide variety of tissues38. Prolactin has also been shown to play a role in more 
than three hundred biological functions including water and electrolyte balance, cell 
proliferation, tumor growth, mammary development and lactation38, and while no 
diseases involving mutations in the genes for PRL or PRLR has been described, 
hyperprolactinemia has been associated with amenorrhea, galactorrhea and 
impotense39. 
Nb2 cells, a lactogen-dependent rat T-cell lymphoma cell line, have been shown to 
proliferate in response to PRL (or growth hormone) from several species40–43. Bivalent 
monoclonal antibodies against the rat prolactin receptor, but not monovalent monoclonal 
antibodies, were capable of activating Nb2 mitogenesis, showing that receptor 
dimerization is a necessary step in prolactin’s bio-activity44,45. To monitor PRL’s bio-
activity in a system of human PRLR (hPRLR) (instead of rat PRLR (rPRLR)), Goffin et al. 
developed an assay, where human embryonic kidney fibroblasts (HEK293) were 
transfected with cDNA encoding either hPRLR or rPRLR, and a prolactin responsive 
reporter plasmid named lactogenic hormone response element LHRE-luciferase46. 
In the hPRLR assay, increasing concentrations of prolactin first act as an agonist for 
biological activation, but at a higher concentration the prolactin becomes a self 
antagonist, resulting in a bell-shaped activity curve. Bell-shaped curves in dose-
response biological assays describe hormone-receptor interactions, where the receptor 
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activation is triggered by ligand mediated sequential receptor dimerization and where the 
affinity of the first binding site is higher than that of the second binding site, which are 
properties shared by all members of the GH/PRL/PL family. The rPRLR assay shows a 
different scenario, where there is no self-antagonistic effect at high hormone 
concentration. Thus the binding affinity of hPRL for rPRLR is about equal for both 
binding sites, indicating that the binding mechanism for prolactin is species specific. This 
observation is in agreement with the results of prolactin-mediated Nb2 cell proliferation46, 
and shows the limitation of the Nb2 experiment as a model for human prolactin activity.  
3.1.1 Molecular	  structure	  of	  prolactin	  
hPRL is a 199 amino acid (aa) protein with a molecular mass of ~ 23 kDa, and the 
extracellular domain of the prolactin receptor, which is soluble in water, is a 206 aa 
protein with a molecular mass of ~24 kDa. All attempts at crystallizing wild type hPRL 
have so far been unsuccessful. The solution structure of hPRL was solved in 2005 by 
Teilum et al. using NMR, and consists of a four helix bundle47 (Fig. 7) with an up-up-
down-down motif. The secondary structure consists four major α-helices, helix 1 (residue 
15-43), helix 2 (residue 78-103), helix 3 (residue 111-137) and helix 4 (residue 161-193), 
a short 310-helix (60-62) and a short α-helix (69-74). The four major helices are bound by 
a short loop between helix 2 and helix 3 and two long flexible loops between helix 1 and 
helix 2 and helix 3 and helix 4 respectively. The two minor helices are both located in the 
flexible loop between helix 1 and helix 2. There is a flexible N-termainal tail (residue 1-
14) and a shorter, less flexible C-terminal tail (residue 194-199), and each tail contains a 
disulfide bridge, between C4-C11 and C194-C199. There is an additional disulfide bridge 
between C54-C174, effectively linking the 310-helix to helix 447.  
The four helix bundle is generic for all members of the GH/PRL/PL family, with whom 
(GH and PL) PRL shares only ~23% amino acid sequence homology47. 
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3.1.2 Receptor	  binding	  sites	  on	  prolactin	  
To identify the two binding sites suggested by the HEK 293 LHRE-luciferase 
experiments, a series of alanine mutagenesis experiments were performed, where the 
effect of single mutations on the biological activity of hPRL was measured. A high affinity 
receptor binding site (HARBS) and a low affinity receptor binding site (LARBS) were 
identified. HARBS is a concave binding site bordered by helix 1, helix 4 and the second 
half of loop 1 (Fig. 8). Alanine scanning mutagenesis has shown thirteen residues that 
are important for HARBS binding: V23, H30, F37, H59, P66, K69, Y169, H173, R176, 
R177, H180, K181, Y185 and K18748–50. The first three are in helix one, the next three in 
the first overhand loop and the last 7 in helix 4. Other residues of interest are H27, N184 
and L188 because of their proximity to HARBS and their accessibility to the solvent. 
LARBS is a different kind of binding site, it is formed by a hydrophobic tunnel between 
helix 1 and helix 3, and consists of a flat binding surface (where HARBS is concave) with 
no “hot spots” (Fig. 9).  Alanine scanning mutagenesis showed five residues important to 
LARBS binding, R21, A22, Y28, R125 and G12946,50–52, and the NMR structure shows 
that six additional residues L18, L25, L126, E128, L132 and I133 either border the 
binding site or form the interior wall of the hydrophobic channel47. 
3.1.3 Binding	  affinity	  of	  prolactin	  and	  prolactin	  receptor	  	  
In an effort to measure the binding affinities of HARBS and LARBS using Surface 
Plasmon Resonance (SPR) Sivaprasad et al. created three mutants of hPRL: M158C-, 
G129C- and K181C hPRL53. The implanted cysteine was used to immobilize the hPRL 
mutant on the sensor chip. The mutation in M158C hPRL is distal from both binding sites 
and should have a minimal effect on their binding properties. The G129C mutation is 
located in LARBS and the K181C mutation is located in HARBS, theoretically disrupting 
binding at these sites. The structural integrity and folding of the mutants was checked by 
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CD-spectroscopy, and the biological activity of the hPRL mutants was verified by their 
ability to induce proliferation in a FDC-P1 cell line transfected with hPRLR. All three 
mutants induced proliferation, but G129C hPRL and particularly K181C hPRL had 
significantly reduced biological activities compared to wild type PRL53. M158C hPRL had 
the same biological activity as wild type PRL53. In the SPR experiment the mutated PRL 
was immobilized, so a more complete blockade of LARBS in G129C hPRL and HARBS 
in K181C hPRL could be expected53. The experiment was run using the extracellular 
domain of the prolactin receptor (hPRLR-ECD) as a ligand. 
The stoichiometry of PRLR binding in the SPR experiment suggested that M158C 
hPRL (the “wild type”) binds two hPRLR-ECDs, and when the results were applied to a 
two-binding site model, M158C hPRL was shown to have a high HARBS and a LARBS, 
albeit of almost equal binding affinity (kD,high 100 nM and kD,low 150 nM). G129C hPRL 
was shown to bind one hPRLR, which is consistent with LARBS being blocked, and 
K181C hPRL, where HARBS is blocked, show no binding affinity towards hPRLR at all. 
This suggests that HARBS needs to be occupied for LARBS to have any binding affinity, 
indicating that HARBS and LARBS are linked by an allosteric effect53. A similar allosteric 
effect has been shown in GH54.  
There are some concerns regarding the magnitude of the binding affinity of LARBS 
found by Sivasprasad et al.53 and the methods employed in their paper. A hormone with 
two receptor binding sites where the binding affinities are as similar as reported by 
Sivasprasad et al. would be a full agonist with no self antagonism at high hormone 
concentration in HEK 293 LHRE-luciferase experiments rather than the observed full 
agonist with self antagonistic properties46. A recent SPR study performed by Jomain et 
al. 2008 immobilized hPRLR-ECD instead of the hormone and found that the binding 
affinities of HARBS and LARBS in wild type hPRL were 6.5 nM and 32.9 µM 
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respectively, which means they are separated by four orders of magnitude55. Such a 
large difference in binding affinities is consistent with the observed results from the HEK 
293 LHRE-luciferase experiments46 and suggests that the M158C mutation Sivasprasad 
et al. used to immobilize the hPRL mutant affects the binding affinity of LARBS. This 
raises the question if the data obtained by Sivasprasad et al. using the other two 
mutants, G129C hPRL and K181C hPRL, represents the properties of wild type hPRL, 
and suggests new SPR experiments with immobilized hPRLR-ECD’s needs to be 
performed on M158C hPRL, G129C hPRL and K181C hPRL to ascertain whether the 
results indicating allosteric coupling between the receptor binding sites are affected by 
the direct immobilization on the sensor chip.  
3.1.4 Molecular	  structures	  of	  prolactin	  –	  prolactin	  receptor	  complexes	  
Further information about PRLR binding has been provided by crystal structures of 
binary and ternary complexes of mutant PRL and PRLR. As stated above, wild type PRL 
has never been crystallized, but PRL variants with altered or truncated N-terminal tails 
have made it possible to probe the interaction of PRL and PRLR. 
3.1.4.1 Crystal	  structure	  of	  prolactin	  receptor	  antagonist	  
Jomain et al. designed Del1-9-(C11S)G129R hPRL as a complete prolactin receptor 
antagonist, since an earlier antagonist, G129R hPRL, still retained the ability to convey a 
small amount of prolactin activity. Jomain et al. found that truncating the flexible N-
terminal region, and substituting C11 with a serine to avoid an unpaired cysteine 
completely removed the ability of the prolactin receptor antagonist to convey prolactin 
activity, leading them to believe that the N-terminal region is involved in LARBS 
binding55. The contribution from the N-terminal tail is only measurable when binding is 
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disabled at LARBS, since N-terminally truncated hPRL without mutations in LARBS 
show no binding affinity changes at LARBS compared to the wild type hPRL55.  
Several other hPRL constructs with combinations of deletions and mutations were 
investigated. Pure vs. partial antagonism didn’t correlate with the affinity towards 
hPRLR, but was inversely proportional to the thermodynamic stability (which is only 
affected by G129 mutations, not deletions). hPRL is flexible around G129, and all 
mutations decrease flexibility and result in a decrease in binding affinity (except proline). 
Proline may induce a bend required for binding, which indicates that flexibility is required 
for the binding of hPRLR at LARBS (ex. G129V)55. 
Jomain et al. successfully crystallized the prolactin receptor antagonist Del1-9-
(C11S)G129R hPRL (the first succesfull crystallization of a prolactin variant). The 
structure of Del1-9-(C11S)G129R hPRL revealed no major structural changes from the 
solution structure of wildtype hPRL55, making it a convenient starting point for attempts 
to crystallize a binary complex of PRL and one hPRLR-ECD. 
Apart from the arginine in the glycine binding pocket of the LARBS there are three 
noteworthy differences between wild type hPRL and the prolactin receptor antagonist: 
the c-terminal end of helix 1 is four residues longer in the antagonist (probably because 
of increased flexibility in the molecule in solution), the disulfide bridge between C191-
C199 doesn’t form (C199 is instead in close contact with S11 from a symmetry-related 
molecule), the C4-C11 disulfide bond doesn’t exist, leading to significantly different 
terminal tails. 
3.1.4.2 Crystal	  structure	  of	  prolactin	  receptor	  antagonist	  in	  complex	  with	  hPRLR-­‐ECD	  
Svensson et al. published a crystal structure of the binary complex of a different prolactin 
receptor antagonist (Del 1-11-(Q12S)G129R hPRL) than the one used by Jomain et al. 
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and hPRLR-ECD56 (Fig. 10). They also performed hydrogen exchange mass 
spectroscopy (HX-MS) and NMR experiments on solutions of the binary complex. 
HX-MS experiments are used as a measurement of structure dynamics, where low 
exchange indicates a closed structure supplying a high protection against exchange with 
the solvent, whereas high exchange indicates an open structure with a higher exposure 
to the solvent. 
The HX-MS data shows that Del 1-11-(Q12S)G129R hPRL the N-terminal end of helix 1 
(residue 16-22) in helix 1 is destabilized in compared to WT hPRL56. This region has 
been shown to be important to BS2 binding, and the destabilization of helix 1 could be 
an alternative explanation (to the direct interaction proposed by Jomain et al.55) of the 
antagonistic properties of truncating the N-terminal tail of PRL. 
Two dynamic regions, I51-S57 in the first overhand loop, and N197-C199 in the C-
terminal tail are indicated to be important for receptor interaction because of significant 
protection from exchange upon receptor binding (the C-terminal tail had not previously 
been indicated as part of HARBS). Regions in helix 2 and 3 that are not part of binding 
at HARBS but important for binding at LARBS, are significantly protected against 
exchange at long exchange times, indicating a conformational stabilization of PRL in that 
region upon hPRLR-ECD binding at HARBS. This observation opens up for the 
possibility of a dynamically driven allosteric effect. 
15N HSQC experiments of Del1-9-(C11S)G129R-hPRL and Del1-9-(C11S)G129R-hPRL 
bound to hPRLR-ECD show markedly perturbed chemical shifts for the residues directly 
involved in hPRLR-ECD at HARBS. The C-terminal residues are again indicated to 
undergo a large shift upon receptor binding56. N56 is markedly deshielded with a 
chemical shift of 10.4 ppm in the binary complex. 
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Contact residues in Del 1-11-(Q12S)G129R hPRL are helix 1 (H27, H30, N31), helix 4 
(H173, R176, R177, H180, K181, D183, N184, Y185, K187, L188, C191, R192), C-
terminal loop 1 (P66, E67, D68, K69, E70, A72, Q73), N-terminal part of loop 1 (I51, 
T52, A54, I55, N56) and C-terminus (N197, N198). 
The crystal structure of Del 1-11-(Q12S)G129R hPRL bound to hPRLR-ECD shows 
that the binding surface of HARBS is about 1200 A2. 
The important binding interactions are as follows: K69 stacks with W139R and forms an 
ion pairing network: K66R-E18R-K69-D134R-K136R (Fig. 11). R177 has an ion and 
hydrogen bonding network involving E43R, T74R, D96R and a water molecule (Fig. 12). 
The disulfide bridge between C191-C199 might be present in the complex and mass 
spectrometry showed it present in the media that the crystal was grown from, but there is 
no density for C199 in the x-ray diffraction. The synchrotron might have damaged the 
C191-C199 disulfide bond, causing C199 to disappear. 
The structure also shows important changes between unbound Del1-9-(C11S)G129R-
hPRL and the binary complex. In the binary complex, A54-S57 forms type II β-turn, and 
I51-A54 is a α-helix, whereas this region in Del1-9-(C11S)G129R-hPRL is unordered, 
but in disallowed region, and invisible in the NMR-structure of WT hPRL (because of 
hydrogen exchange brought upon by high pH and high flexibility). This restructuring 
leaves the side chains of I51 and I55 exposed to undergo hydrophobic interactions with 
the receptor residues Y94R and I76R, and allow tight backbone and sidechain H-bonds to 
E43R and G44R. The stable R43-R48 region in the crystal structure of Del1-9-
(C11S)G129R-hPRL is probably due to crystal packing according to Svensson et al. 
The C-terminal part of hPRL is radically different between the unbound Del1-9-
(C11S)G129R-hPRL and the binary complex of Del 1-11-(Q12S)G129R hPRL and 
hPRLR-ECD. But since the C191-C199 disulphide bridge doesn’t form in the antagonist 
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(Del1-9-(C11S)G129R-hPRL), and C199 has no density in the complex, comparison is 
moot. C-terminus structure and binding activity should be interpreted with caution 
because of this. 
As for a allosteric effect, there is significant changes in the PRL structure upon 
receptor binding, including the stabilization of the C-terminal part of helix 1, but the 
crystal structure reveals no significant changes at the residues important for binding at 
the second binding site upon binding of the first receptor56.  
The allosteric mechanism proposed for hGH (an rearrangement through a hydrophobic 
motif57) doesn’t seem likely in hPRL, since the corresponding residues, F50, L98, Y169, 
L172 and H173, with the exception of F50, don’t undergo significant rearrangements 
upon binding. A classic allosteric effect caused by conformational structure changes is 
therefore unlikely to take place in hPRL upon binding of hPRLR-ECD at HARBS. 
3.1.4.3 Crystal	  structure	  of	  affinity-­‐matured	  prolactin	  in	  complex	  with	  two	  rPRLR-­‐ECD	  
Broutin et al. 2010 published a crystal structure of a ternary complex between an affinity 
matured hPRL variant ((Full-oPL-Nter)hPRL) and two rPRLR-ECD58. 
oPL binds tighter to PRLR-ECD than hPRL, and a good part of the binding energy stems 
from the N-terminal tail of oPL. In order to mimic this tighter binding the N-terminal tail of 
hPRL was replaced by the N-terminal tail of oPL to make the (Full-oPL-Nter)hPRL 
construct. 
The main differences between N-terminal tail of hPRL and the N-terminal tail of oPL is: 
1. A	  proline	  right	  before	  helix	  1	  in	  oPL	  (position	  14	  in	  hPRL).	  
2. AQHPPY	  motif	  located	  before	  the	  N-­‐terminal	  disulphide	  bridge	  in	  oPL	  (at	  Cys4).	  
3. The	  short	  loop	  bordered	  by	  the	  N-­‐terminal	  disulphide	  bridge	  is	  RNQP	  in	  oPL	  
instead	  of	  PGGA	  in	  hPRL,	  moving	  the	  P	  from	  position	  5	  to	  8.	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Mutants were devised testing these differences individually and together, and the oPL N-
terminal tail stabilizes complex, with an additional H-bond, but only certain mutants, full 
oPL and PGGA-T14P stabilizes complex, so it seems likely that special fold of N-
terminal is required58. The binding constant of the second hPRLR was still about 16000 
nM, but for rPRLR it was now 300 nM, and Broutin et al. were therefore able to 
successfully crystallized the ternary complex of (Full-oPL-Nter)hPRL-2rPRLR (Fig. 13).  
7 of the 28 residues that interact with hPRL differ between rPRLR and hPRLR, but the 
structure of prolactin in the ternary complex with two rPRLR and the structure of Del 1-
11-(Q12S)G129R hPRL bound to a single hPRLR overlays very well, indicating that the 
differences between rPRLR and hPRLR only have negligible effect on the overall 
complex structure58.  
The resolution of the complex structure is relatively low, but adequate to observe 
backbone structure. The binding surface of LARBS is about 700 A2 in (Full-oPL-
Nter)hPRL. It is composed of 3 major features:   
1. The	  glycine	  pocket	  around	  G129,	  which	  is	  the	  major	  contributor.	  	  W72R2	  fit	  in	  the	  
cavity.	  
2. A	  possible	  hydrogen	  bond	  network	  in	  the	  glycine	  cavity	  that	  cannot	  be	  resolved	  
because	  of	  the	  low	  resolution	  of	  the	  complex.	  D17	  and	  R21	  are	  in	  close	  proximity	  
of	  Asp96R2	  and	  Thr98R2,	  and	  are	  thus	  good	  candidates	  for	  such	  a	  network.	  
3. The	  elongated	  oPL	  N-­‐terminus	  adds	  a	  hydrogen	  bond,	  in	  this	  case	  Y3	  to	  D96R2	  
When you superimpose the structures of free PRL and PRL in complexes (using helix 2, 
the only helix not involved in receptor binding) HARBS pulls at the lower end of helix 1 
and 4, causing an opposing movement on the upper helices, which bend around hinges 
in the alpha helices58. After these significant structure changes occur upon binding of the 
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first receptor, the structure of (Full-oPL-Nter)hPRL stays  the same when the second 
receptor binds, i.e. the receptor accommodates the ligand (since (Full-oPL-Nter)hPRL-
2rPRLR-ECD overlays very well with Del 1-11-(Q12S)G129R hPRL-hPRLR-ECD). This 
is a trait seen in both hGH and oPL, albeit to different degrees. 
3.1.5 Biophysical	  investigation	  of	  prolactin-­‐receptor	  binding	  
While the interaction of PRL and PRLR thus has been the subject of intense study, 
several questions remain. The PRL variants used to crystallize PRL-PRLR complexes 
are heavily modified and it has yet to be shown if wild type prolactin shares their 
interaction mechanisms, and while the structures of hPRLR-ECD and rPRLR-ECD 
complexes with PRL variants are similar, that is not necessarily the case for wt hPRL. In 
this study we will use NMR studies of wt hPRL and hPRLR-ECD to provide an answer to 
this question.  
The ternary complex of wt hPRL has been visualized using size exclusion FPLC and 
native PAGE by Teilum et al.47, but in our studies we have been unable to reproduce 
these results, so we perform a hPRLR-ECD titration series of wt hPRL to monitor 
complex formation. This PRLR-ECD titration will also allow the extraction of the binding 
affinity of the HARBS and LARBS on PRL for PRLR-ECD, which can complement the 
binding affinities found by SPR53,55. 
Finally the reported allosteric coupling between its receptor binding sites53 isn’t 
explained by the observed conformational structure change56 upon receptor binding at 
the HARBS of hPRL, indicating that conformational entropy changes at the receptor 
binding site could be an important factor driving this proposed allosteric effect. In order 
to shed light on this possibility this study will utilize NMR relaxation and model-free 
analysis experiments to determine the dynamic properties of the backbone amides in 
unbound hPRL and hPRL in the binary hPRL:hPRLR-ECD complex. A comparison of 
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the dynamic properties of hPRLs structure before and after receptor binding will reveal 
any conformational entropy change in the backbone of hPRL upon receptor binding, 
possibly shedding new light on the role of entropy in biological processes.  
3.2 Materials and methods 
3.2.1 Expression	  and	  purification	  of	  recombinant	  hPRL	  and	  hPRLR-­‐ECD	  
Expression, refolding and purification of recombinant wildtype hPRL from inclusion 
bodies were performed using a protocol modified from Teilum et al. 47. Fully deuterated 
recombinant wild type 15N- and 15N,13C-hPRL were expressed in E.Coli BL21(DE3) from 
a pT7-hPRL vector. The bacteria were grown in minimal 2H2O-M9 medium containing 
15NH4CL and 2H,13C-glucose or 15NH4CL and 2H-glucose as the sole nitrogen and carbon 
sources. The cells were grown at 37 °C until OD600 of 0.9, after which protein expression 
was induced by 1 mM IPTG for 6 hours at 37 °C. After harvesting the cells were frozen 
at -80 °C overnight, resuspended in 50 mM Tris HCl, 0.5 mM EDTA, 1 mM AEBSF, pH 
8.0 and disrupted by sonication. The protein is in inclusion bodies, which were washed 
three times in 10 mM Tris HCl, 1 mM EDTA, pH 8 and denatured in 5 M GuHCl, 0.2 M 
Na2HPO3, 0.2% DTT, pH 7.0 at a protein concentration of 0.1 mg/mL. Refolding was 
performed by dialysis against a 20 mM NH4HCO3, 200 mM NaCl, pH 8.0 buffer until the 
GuHCl concentration < 0.1 M, preferably even lower. The sample is then concentrated 
and purified using a HiLoad 16/60 Superdex 75 column (GE Healthcare) followed by 
desalting and final purification step using a HiTrap 5mL Q Sepharose HP column (GE 
Healthcare).  
Expression, refolding and purification of unlabeled recombinant hPRLR-ECD from 
inclusion bodies were also performed using a protocol modified from Teilum et al. 47.	  
hPRLR-ECD was expressed in E.Coli BL21(DE3) from a pT5-hPRL vector, and the 
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bacteria were grown in LB medium. The cells were grown at 37 °C until OD600 of 0.8, 
after which protein expression was induced by 1 mM IPTG for 4 hours at 37 °C. After 
harvesting the cells were frozen at -80 °C overnight and then resuspended in 40 mL 
PBS, 25% sucrose, 5 mM EDTA, 1% Triton X-100, pH 7.4 and disrupted by sonication. 
The protein is in inclusion bodies, which were washed three times in the same buffer, 
and then denatured in 50 mM Tris-HCl, 6 M Urea, 0.2% DTT, pH 9.0 at a protein 
concentration of 0.1 mg/mL. Refolding was performed by dialysis against a 50 mM Tris-
HCl, 10 mM cysteamine, 1mM cystamine, pH 9 buffer until the Urea concentration < 0.1 
M. The sample is then concentrated and purified using a HiLoad 16/60 Superdex 75 
column (GE Healthcare) followed by desalting and final purification step using a HiTrap 
5mL Q Sepharose HP column (GE Healthcare).  
3.2.2 FPLC	  study	  of	  hPRL:hPRLR-­‐ECD	  complex	  formation	  
In order to observe hPRL:hPRLR-ECD complex formation using FPLC with a HiLoad 
16/60 Superdex 75 size exclusion column (GE Healthcare), three samples were 
prepared with different hPRL: hPRLR-ECD concentration ratios (table 2). 
The binding affinities for the HARBS/LARBS on hPRL for hPRLR-ECD have been 
reported by two different groups, Sivaprasad et al.55 and Jomain et al.53, both of whom 
used an SPR approach, but their results are very different. Our approach will be able to 
discern which claim is most accurate, since the FPLC profiles of hPRLR-ECD binding 
using a size exclusion column would be radically different depending on which scenario 
is correct.  
If the claim by Sivaprasad et al. is correct, and the binding affinities for the 
HARBS/LARBS are almost equal (kD of HARBS = 100 nM/LARBS = 150 nM), the 
binding affinities are so close and so strong that at the concentration ratio 1:1, the 
populations of hPRL in unbound form, in the binary complex and in the ternary complex 
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should all be about equal resulting in peaks of similar size, since the binary complex 
would compete with the unbound hPRL for the hPRLR-ECD. At ratio 1:2 there would be 
lone peak for the ternary complex, and at ratio 1:4 a peak for the ternary complex and 
one for unbound hPRLR-ECD would be visible. 
If the claim by Jomain et al. is correct, and the binding affinities of the HARBS and 
LARBS are separated by four orders of magnitude (kD of HARBS =  6 nM/LARBS = 33 
µM), the binding affinity of the LARBS is so low, that it is not guaranteed that it is 
possible to observe the ternary complex at the chosen concentrations and conditions. At 
the concentration ratio 1:1 a single peak corresponding to the binary complex would be 
expected, due to the four orders of magnitude between the binding affinities of HARBS 
and LARBS. At concentration ratio 1:2 and 1:4 peaks for the binary complex and 
unbound hPRLR-ECD would be readily observable, and it is possible that a smaller peak 
for the ternary complex would be visible under the chosen conditions depending on the 
protein concentration in the eluate. At concentration ratio 1:2, the concentration of 
ternary complex in the 1 mL injection mixture is about a fifth of the binary complex 
concentration (33 µM/6 µM free hPRLR-ECD ~ 20%) and at the 1:4 concentration ratio 
the ternary complex concentration in the 1 mL injection mixture is about its about a third 
of the binary complex concentration (33 µM/ 9 µM free hPRLR-ECD ~ 33%). 
The running buffer 20 mM NH4HCO3, 50 mM NaCl, pH 8.0 at 4 °C, the flowrate was 1 
mL/min and the injection volume was 1 mL. Under these circumstances, the void volume 
of the column is 45 mL, and the elution volume of hPRL and hPRLR-ECD are both 
around 66 mL due to their similar size. 
3.2.3 NMR	  samples	  and	  instrumentation	  
The large size of the binary hPRL:hPRLR-ECD complex (47 kD) causes NMR 
relaxation rates (R2) to be very fast, which leads to severe line-broadening of the NMR 
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signals and low signal-to-noise NMR spectra.  In order to reduce this problem fully 
deuterated protein samples were produced, and hydrogens were allowed exchange to 
the amide groups in the proteins. The reduced density of hydrogen in the protein 
reduces the relaxation mechanisms presented to the amide hydrogens, which leads to 
decreased relaxation rates and thus significantly decreased linewidths and increased 
signal-to-noise ratios59. 
The NMR sample of hPRL used to assign the resonances from hPRL was 400 µM 
deuterated 13C 15N hPRL, 50 mM KPO4, 10% D2O, 0.02% NaN3, pH 7.0 at 35 °C while 
the sample used to determine the relaxation properties of hPRL was 500 µM deuterated 
15N hPRL, 50 mM HEPES, 50 mM NaCl, 10% D2O, 0.02% NaN3, pH7 at 35 °C. The 
NMR samples used to assign the resonances from the binary hPRL:hPRLR-ECD 
complex was 200 µM deuterated 13C 15N hPRL, 240 µM unlabeled hPRLR-ECD, 20 mM 
MOPS, 20 mM NaCl, 10% D2O, 0.02% NaN3, pH 7.0 at 35 °C, while the sample used to 
probe the relaxation properties of hPRL in the binary hPRL:hPRLR-ECD complex was 
200 µM deuterated 15N hPRL, 240 µM unlabeled hPRLR-ECD, 20 mM MOPS, 20 mM 
NaCl, 10% D2O, 0.02% NaN3, pH 7.0 at 35 °C.  
The hPRLR-ECD titration of hPRL used a 200 µM 15N hPRL, 20 mM MOPS, 20 mM 
NaCl, 10% D2O, 0.02% NaN3, pH 7.0 at 35 °C sample and addition of hPRLR-ECD in 
the same buffer. All complex samples were mixed at a protein concentration of 1 mg/mL 
to avoid excessive aggregation and then concentrated to their target concentration. 
All NMR spectra were recorded on Varian/Agilent VNMRS 500, 600 and 800 
instruments equipped with 5 mm HCN inverse cold probes with z-axis gradient. 
3.2.4 Assigning	  the	  NMR	  resonances	  
138 (out of 199) of hPRLs amide backbone resonances have been assigned at pH 8, 
37 °C47. The missing assignments are mostly located in the N-terminal tail and the two 
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overhand loops, which are all regions of interest in receptor binding. Since fast amide 
exchange at pH 8 is likely a contributing factor to the assignment gaps, an effort was 
taken fill them in at pH 7, where the amide exchange is slower, using 15N-HSQC60, 
HNCO61–64, HNCACB63–65 and HNCACO66 experiments from the Biopack library 
(Varian/Agilent).  
Transverse relaxation optimized spectroscopy (TROSY) versions of the NMR 
experiments67 were used in order to decrease size induced line-broadening low signal-
to-noise ratios when studying the binary hPRL:hPRLR-ECD complex (47 kD). TROSY 
reduces linewidths and increases sensitivity by selectively choosing to monitor the 
slowest relaxing component of the multiplets, which arises in undecoupled 
multidimentional NMR spectra. The slow relaxation of the chosen multiplet-components 
is caused by cross-correlation between DD- and CSA relaxation. The assignments of the 
hPRL resonances from the binary hPRL:hPRLR-ECD complex were determined using 
the TROSY versions67 of  15N-HSQC, HNCO, HNCA61–64, HNCACB and HNCACO 
experiments from Biopack library (Varian/Agilent). 
The 15N-HSQC, HNCO, HNCACB and HNCACO experiments were processed with the 
Rowland NMR Toolkit and interpreted with NMRViewJ68. 
3.2.5 NMR	  monitored	  hPRLR-­‐ECD	  titration	  of	  hPRL	  
A titration series of a 200 µM 15N-hPRL, pH 7.0 solution at 35 °C with increasing 
amounts of unlabeled hPRLR-ECD was performed to monitor complex formation. The 
titration concentrations can be seen in table 3. 
Each titration step is monitored by a TROSY67 enhanced 15N-HSQC60 spectrum 
recorded at 600 MHz, in which the unlabeled hPRLR-ECD is invisible. It is thus only the 
signals arising from amides in hPRL, both in the free, unbound state and in complex with 
hPRLR-ECD, that are monitored. Each titration step includes diluting the sample to 0.1 
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mg/mL, mixing the sample with additional hPRLR-CD and concentrating the sample 
again to minimize aggregation. 
3.2.6 NMR	  relaxation	  studies	  of	  hPRL	  
The 15N longitudinal (R1) and transverse (R2) relaxation rates and the heteronuclear 
15N 1H steady-state NOE of unbound hPRL were measured by the T1- and T2 relaxation 
experiments69,70 and the NOE70 experiment from the Biopack library (Varian/Agilent). 
TROSY67 enhanced versions of these experiments the Biopack library (Varian/Agilent) 
were used to measure the 15N longitudinal (R1) and transverse (R2) relaxation rates and 
the heteronuclear 15N 1H steady-state NOE of hPRL in the binary hPRL:hPRLR-ECD 
complex. The spectra were processed using NMRPipe71, MUNIN72 and DASHA24 
software packages. The errors of the recorded R1, R2 and NOE values were estimated 
as described73, with a lower limit of 3% of the R1 and R2 measurements and 0.05 for the 
NOE measurements. 
3.2.7 Model-­‐free	  analysis	  of	  the	  NMR	  relaxation	  data	  by	  DASHA	  
The DASHA24 software package was utilized in order to obtain the model-free 
parameters for each individual backbone NH vector. DASHA determines the parameters 
of different models for the molecular motion correlation function Ct(t), which consists of 
product of the correlation function of overall molecular motion Cm(t) and internal 
molecular motion Ce(t), by least square fits using the experimentally obtained NMR 
relaxation data from multiple magnetic fields simultaneously (method description21). The 
models for overall motion and internal motion can be seen in table 1. The parameters 
extracted for each model was the generalized order parameter, S2, which represents the 
spatial restriction of the intramolecular motions, the correlation times of these motions 
and the rotational diffusion tensor DΓ, which describes the overall anisotropic tumbling of 
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the molecule. The models are divided by the timescales they cover, where model 1 and 
3 in table 1 describes internal motions on the picosecond timescale12, while model 5 
describes motions on both the picosecond and the nanosecond time scale23. The 
models are also divided by whether is assumed that the fast internal motions are shorter 
than few picoseconds and thus assumed to be zero (model 1 and 5 in table 1) or not 
(model 3 in table 1). The rotational diffusion tensor consists six parameters: the ratios of 
the eigenvalues of DΓ (𝐷! 𝐷! and 𝐷! 𝐷!), the overall rotational correlation time τm, which 
is equal to !! 𝐷! + 𝐷! + 𝐷! , and the directions of the axes of DΓ in the molecular frame, 
which is described by the Euler angles α, β and γ. If DΓ is axially symmetric it is defined 
by four parameters: τm, 𝐷∥ 𝐷!, α and β. 
In order to make a comparison with the experimental NMR relaxation data, the DΓ of 
unbound hPRL and hPRL in the binary hPRL:hPRLR complex was predicted by the 
DIFFC program24, which uses hydrodynamic calculations in a beads model 
approximation21,74,75. DIFFC can create bead models from PDB files, by placing beads 
with a 0.35 nm radius at the spatial position of Cα atoms. The solution structure for hPRL 
is known (PDB code 1RW5)47 and there is a crystal structure for a truncated prolactin 
receptor antagonist in complex with one hPRLR-ECD (PDB code 3D48)56, which is a 
good approximation for the structure of the binary hPRL:hPRLR-ECD. These structures 
allowed the prediction of DΓ, and thus τm, of unbound hPRL and hPRL in the binary 
complex. 
The model-free analysis is separated into three steps:  
1. Estimation	  of	  the	  overall	  rotational	  parameters	  of	  the	  molecule	  
2. The	  models	  of	  internal	  motion	  are	  defined	  for	  individual	  residues	  and	  the	  most	  
appropriate	  models	  selected	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3. Fine	  tuning	  of	  the	  adjustable	  parameters	  
In the first step the overall rotation parameters is estimated by testing six different 
combinations of models for Cm (model 6, 7 and 8 in table 1) and Ce (model 1 and 3 in 
table 1) in the minimization of the cumulative loss function73, using experimental NMR 
relaxation data from residues in rigid regions of hPRL (NOE > 0.7 at 500 MHz, and R1 
and R2 values within two standard deviations of the average) at two field strengths. The 
most appropriate model was chosen using χ2 and F statistics76, allowing the estimation 
of the global adjustable parameters defining the overall rotation of the molecules. 
In the second step the models for internal motion (model 1-5 in table 1), in which the 
parameters for the overall rotation of the molecule estimated in the first step has been 
fixed, are determined for each individual residue. Model 2 and 4 are created by adding 
an adjustable contribution to R2 representing chemical exchange (Rex) to model 1 and 3 
in table 1. A statistical protocol21,22,77 is then used to determine the most appropriate 
model for each residue. 
In the final step of the model-free analysis a simultaneous fit of all the selected models 
for overall rotation and internal motion are performed, fine tuning the model-free 
parameters extracted from the analysis. 
In all the model-free calculations the 1H-15N internuclear distance was set to 0.102 nm 
and the 15N chemical shift anisotropy was set to -170 ppm. 
3.3 Results 
3.3.1 Purification	  of	  hPRL	  and	  hPRLR-­‐ECD	  
The 15N HSQC spectra of the recombinant hPRL were well dispersed (Fig. 14) and 
thermal unfolding monitored by CD-spectroscopy was cooperative (data not shown). 
Both observations indicate a folded protein. 
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Purification of unlabeled recombinant hPRLR-ECD was monitored by SDS-Page and 
size exclusion columns and efficient binding to hPRL was observed by 15N HSQC 
spectra and native-page (data not shown). 
3.3.2 FPLC	  study	  of	  hPRL:hPRLR-­‐ECD	  complex	  formation	  
The size exclusion profiles from the FPLC experiments can be seen in fig. 15. All three 
profiles consist of two peaks, on at 55 mL elution volume and one at 66 mL. The 1:1 
hPRL:hPRLR-ECD profile shows a large peak at 55 mL, encompassing almost the entire 
protein volume, which consists of the 1:1 binary complex, and a small peak at 66 mL 
consisting of either unbound hPRL or hPRLR-ECD. This observation does not fit with the 
binding affinities of HARBS and LARBS reported by Sivaprasad el al. (100nM/150nM), 
but it is compatible with the binding affinities reported by Jomain et al.73 (6 nM/33 µM).  
The 1:2 and 1:4 profile also shows two peaks for the binary complex and the unbound 
hPRLR-ECD, and even in the case of the 1:4 hPRL:hPRLR-ECD ratio sample there is 
no sign of the ternary complex. With a molecular weight of ≈ 70 kD the peak from the 
ternary complex should have been close to the void volume of the Superdex 75 size 
exclusion column. The concentration of unbound hPRLR-ECD (peak at 66 mL) in the 1:2 
concentration ratio experiment is ~ 0.7 µM/mL in 7.5 mL eluate (total amount of unbound 
hPRLR-ECD ~ 5.2 µM) and in the 1:4 concentration ratio experiment is ~ 1.1 µM/mL in 
7.5 mL eluate (total amount of unbound hPRLR-ECD ~ 8,3 µM).  
These observations are again at odd with the HARBS/LARBS affinities reported by 
Sivaprasad et al, where the kD of 150 nM would have resulted in a single peak for the 
ternary complex in the 1:2 ratio sample and a peak for the ternary complex and one for 
unbound hPRLR-ECD in the 1:4 ratio sample, while they could fit nicely with the affinities 
reported by Jomain et al. Given a LARBS kD of 33 µM, the concentration of the ternary 
complex should be about 2% and 3.5% (33 µM/0.7 µM and 33 µM/1.1 µM free hPRLR-
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ECD) of the binary complex concentration, so low that detection would be unlikely. 
These result cannot confirm that the binding affinity of LARBS on hPRL for hPRLR-ECD 
is the 33 µM suggested by Jomain et al. or that the ternary complex forms at all, but it is 
shown that the kD must be substantially higher than 1.1 µM. 
3.3.3 Assigning	  hPRL	  resonances	  
Due to the slower amide exchange at pH 7.0 (compared to pH 8.0) an additional 38 
backbone amides were successfully assigned in hPRL, resulting in a total of 176 
assigned backbone amino acids out of 199 (88%). 
Strong binding between hPRL and hPRLR-ECD at the HARBS resulted in the peaks 
from the binary complex appearing at their final destination with no trace. 
167 of 199 (84%) of the hPRL backbone amides in the binary complex were 
successfully assigned using 3D NMR experiments as described. 
The observed chemical shift changes of the backbone amides upon receptor binding 
can be seen in figure 16B. The residues in hPRL experiencing the largest chemical shift 
changes (>0.45) upon formation of the binary complex with hPRLR-ECD are located in 
helix 1 and 4, the first overhand loop and the c-terminal tail. These residues have been 
marked on the structure of unbound hPRL (figure 16C), and they closely overlap with the 
residues suggested to be part of the HARBS by findings of Svensson et al.56, who used 
the crystal structure of a prolactin receptor antagonist and the hPRLR-ECD. Moderate to 
minor chemical shift changes (< 0.45) can be found neighboring the HARBS, but they 
also appear in regions distal to the HARBS, for example in helix 3, indicating a structural 
rearrangement of hPRL after association with hPRLR at the HARBS. This observation 
agrees with the information about the structure of the binary hPRL:hPRLR complex 
gained from x-ray crystallography56,58. 
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The observed chemical shift changes generally agree with the chemical shift changes 
reported for a prolactin receptor antagonist in complex with a single hPRLR-ECD 
reported by Svensson et al. 200856. 
3.3.4 NMR	  monitored	  hPRLR-­‐ECD	  titration	  of	  hPRL	  
The 15N-HSQCs recorded during the hPRLR-ECD titration of hPRL can be seen in fig. 
16 and 17. Titration step 1, 2 and 3 in table 3 are shown in fig. 16A, while titration step 4, 
5 and 6 in table 3 are shown in fig. 17A. Visible protein aggregation was observed in the 
last titration step (step 6 in table 3), indicating that the sample was saturated with 
hPRLR-ECD.  
The signal volumes are normalized against an average of three residues, that are 
distal to both HARBS and LARBS and doesn’t undergo chemical shifts during the 
hPRLR-ECD titration. The total volume of the signal for the each residue is calculated as 
the sum of volumes of the signal for the residue in the free unbound state and in the 
binary complex. 
The 15N HSQC spectra in Fig 16A shows the formation of the binary hPRL:hPRLR-
ECD complex, with signals from originating from residues in the free, unbound hPRL 
decreasing, while new peaks corresponding to residues in the binary complex growing in 
at the same rate (Fig. 16D). Residues not experiencing any chemical shift changes upon 
receptor binding have constant signal volume (Fig. 16D). The lack of a trace between 
the original positions of the signals and their final positions indicates strong binding, and 
the rate of conversion from free, unbound hPRL in titration steps 1-3 fits well with the 
binding affinity (KD) for hPRLR-ECD binding at the HARBS on hPRL of 2 nm reported by 
Jomain et al.55.  
The 15N HSQC spectra in Fig. 17A shows the formation of the ternary hPRL:2hPRLR-
ECD complex. It is readily observable that increasing amounts of hPRLR-ECD doesn’t 
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result in significant chemical shift changes of most hPRL signals, indicating that hPRL 
doesn’t undergo structural changes upon binding the second hPRLR-ECD, but a subset 
of 40 residues (I3, C4, G7, R10, T14, L15, R16, D17, F19, D20, V23, V24, L25, H27, 
S33, E67, Q71, Q73, E121, Q122, T123, R125, L126, L127, G129, L132, S135, V137, 
R177, L186, L188, K190, C191, R192, I194, H195, N196, N197, N198, C199) loses 
signal volume in titration step 5 and 6 (G129 shown in Fig. 17C), indicating that these 
residues undergo a chemical shift change. 25 of these residues (I3, C4, G7, R10, T14, 
L15, R16, D17, F19, D20, V23, V24, L25, H27, S33, E121, Q122, T123, R125, L126, 
L127, G129, L132, S135, V137) are located in or around the LARBS on hPRL suggested 
by alanine scanning mutagenesis and the N-terminal tail (Fig. 17B), which was found to 
be implicated in hPRLR binding during development of a hPRLR antagonist55, showing 
that the ternary complex are formed in titration step 5 and 6 from table 3. Fifteen 
residues (E67, Q71, Q73, R177, L186, L188, K190, C191, R192, I194, H195, N196, 
N197, N198, C199) undergoing chemical shift changes during ternary complex formation 
are located adjacent to the HARBS, distal to LARBS. Of these eleven residues, three 
(E67, Q71, Q73) are located in the first overhand loop between helix 1 and 2, while 
twelve (R177, L186, L188, K190, C191, R192, I194, H195, N196, N197, N198, C199) 
are located in the c-terminal end of helix 4 and the C-terminal tail (Fig. 17B). The 
distance between the affected residues and the LARBS and the proximity to the HARBS 
(R177 and N197 are contact residues in HARBS) talks against the changes being a 
result of direct interaction with the second hPRLR-ECD; in all likelihood the chemical 
shift changes are a result of the hPRLR-ECD associated with the HARBS shifting slightly 
due to the stem-stem interaction between the two hPRLR-ECD’s in the ternary complex. 
H27 and S33 on helix 1 are both located close to the LARBS (L25 is the closest LARBS 
residue), but H27-N31 are contact residues in HARBS, so it is an open question if the 
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chemical shift change caused by the association of the second hPRLR-ECD or a shift of 
the first hPRLR-ECD during the formation of the ternary complex. 
Due to signal overlap it isn’t readily observable if several of the residues indicated to 
be part of the LARBS by alanine scanning mutagenesis loses volume upon ternary 
complex formation (for example 130, 131). 21 new signals appear during titration step 5 
and 6 (Figure 17A), but there is no trace to them from the binary complex signals, 
indicating low affinity binding with slow exchange. Their volume increase as a result of 
increasing the hPRLR-ECD concentration (going from titration step 4, 5 and 6), making it 
likely that they stem from hPRL in the ternary hPRL:hPRLR-ECD complex, as does the 
increased line width of the newly emerged signals (~50 Hz compare to ~25-30 Hz for the 
residues in the binary complex. Since there are no traces to the new signals there is no 
easy way to assign them, and low sensitivity due to low protein concentration (caused by 
protein aggregation) and size dependent line broadening (ternary complex is 71 kD) 
makes assignment by 3D NMR techniques challenging, but for certain residues, for 
example Q122, it seems likely that the newly emerged signals stem from the same 
residue as the nearest signal from the binary complex that loses volume upon titration 
with hPRLR-ECD (Fig. 17D). Residues without such a nearby candidate, indicating a 
large chemical shift change, are mostly located in close proximity to G129, the central 
residue of the glycine binding pocket, and the flexible N-terminal tail, regions thought to 
directly interact with the second hPRLR-ECD. Observing a ternary complex formation at 
step 6 in table 3 of between 70-80% of the hPRL population (G129 and Q122) allows a 
rough estimation of the kD of the hPRLR-ECD association at the LARBS. The free 
hPRLR-ECD concentration after binary complex formation = 400 – 200 = 200 µM, and if 
ternary complex formation are estimated to ~ 75%, it follows that the ternary complex 
concentration is ~ 0.75*200 ~ 150 µM, while the free hPRLR-ECD concentration is ~ 200 
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– (0.75*200) ~ 50 µM, and the concentration of the binary complex is ~ 200 – (0.75*200) 
~ 50 µM. The kD of the hPRLR-ECD association at the LARBS can thus be estimated to 
be ~ (50*50)/150 ~ 16 µM. Given the visible aggregation of hPRLR-ECD in titration step 
6 in table 3, and the following uncertainty regarding the protein concentrations, the 
actual kD could very well be the 33 µM proposed by Jomain et al.55. 
3.3.5 NMR	  relaxation	  studies	  of	  hPRL	  
145 backbone amide R1, R2 relaxation rates and steady-state NOEs (Fig. 18A-C) were 
recorded for hPRL at 500 MHz and 800 MHz (of 176 assigned backbone amides), and 
local, per residue τm (Fig 18D) were estimated using these measurements as described 
earlier. Rates from 28 assigned backbone amides were unobtainable due to low 
sensitivity or peak overlap.  
144 backbone amide R1, R2 relaxation rates and steady-state NOEs (Fig. 18F-H) were 
successfully recorded for hPRL in the binary hPRL:hPRLR-ECD complex at 600MHz 
and 800 MHz (of 167 assigned backbone amides), leaving rates from 23 assigned 
backbone amides unobtainable due to low sensitivity or peak overlap. The per residue 
τm’s were estimated from the R2/R1 ratio using DASHA (Fig.18I). 
3.3.6 Model-­‐free	  analysis	  of	  hPRL	  using	  DASHA	  
Using the approach described in the Materials and Methods chapter it was determined 
that the most statistically justified description of the recorded NMR relaxation data (R1, 
R2 and NOE) of both unbound hPRL and hPRL in the binary complex with hPRLR-ECD 
at two field strengths is an axially symmetric tensor of the overall rotational diffusion. 
The parameters of the axially symmetric anisotropic tumbling (τm = 13.34 ns, 𝐷∥ 𝐷! = 
0.8183 for unbound hPRL, τm = 29.67 ns, 𝐷∥ 𝐷! = 0.7487 for hPRL in the binary 
complex) fits well with the parameters obtained from hydrodynamic calculations 
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performed using the solution structure of hPRL47 (PDB entry 1RW5) and the crystal 
structure of a truncated prolactin receptor antagonist in complex with a single hPRLR-
ECD56 (PDB entry 3D48). 
The parameters obtained from the model-free analysis performed as described in the 
Materials and Methods chapter, and the model chosen for the individual residue, are 
shown in table 4 (unbound hPRL) and table 5 (hPRL in the binary complex) and the 
generalized order parameter (S2) of each residue in unbound hPRL (Fig. 18E) and hPRL 
in the binary complex (Fig.18J) (it is assumed that 𝑆! = 𝑆!!𝑆!!) has been plotted. 
As it can be seen in the plots, the generalized order parameter S2 of the residues in 
helix 1-4 are ~ 0.9 indicating highly restricted structural movements, i.e. a very rigid 
structure, in both unbound hPRL and hPRL in the binary complex with hPRLR-ECD.  
In the unbound hPRL the N- and C-terminal tails and the loops connecting the helices 
generally have low-order S2 values, indicating flexibility, but exceptions to this are 
residues located in close proximity to C58 in the first overhand loop between helix 1 and 
2, which is connected to C174 in helix 4 by a disulphide bridge, and the surface exposed 
W150 in the second overhand loop between helix 3 and 4, whose hydrophobic side 
chain are “sticking” to the surface of hPRL.  
In hPRL in the binary complex with hPRLR-ECD the residues in the first overhand loop 
and the C-terminal tail have S2 values of ~ 0.9, on par with the residues in the four 
helices, while the residues in the N-terminal tail, the second overhand loop between 
helix 3 and 4 loops between helix 2 and 3 and the short loop between helix 2 and 3 have 
low-order S2 like in the unbound hPRL. This is illustrated in figure 18K, where ΔS2, the 
difference between the S2 parameters of unbound hPRL and hPRL in the binary complex 
with a single hPRLR-ECD, are plotted, and it can be seen that the only changes outside 
of the margin of error are positive ΔS2 in the first overhand loop and the C-terminal tail of 
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hPRL, illustrating a significant stiffening or stabilization of these areas in the binary 
complex with hPRLR-ECD. 
 Models assuming fast picosecond scale internal dynamics are shown to represent the 
best choice for a majority of the residues in both unbound hPRL (107 of 145 residues) 
and hPRL in the binary complex with a single hPRLR-ECD (118 of 144 residues). In the 
case of the unbound hPRL the models assuming very fast internal dynamics, and thus a 
spectral density function only depending S2, are chosen for ~ 100 of these residues 
(table 4), while the distribution between models assuming very fast internal dynamics 
and those assuming dynamics on the picosecond time scale is about even for hPRL in 
the binary complex with hPRLR-ECD (table 5). The values of the parameterized internal 
dynamics correlation time τe in the binary complex are mostly in the low picosecond time 
scale (table 5). 
In both the unbound hPRL and in hPRLR in the binary complex, the residues that 
exhibit nanosecond motions in addition to the very fast picosecond internal dynamics are 
all located in the flexible regions described by low order S2, which means that the 
regions stabilized by complex formation (first overhand loop between helix 1 and 2 and 
the C-terminal tail) loses their nanosecond structural dynamics (table 4 and 5).  
20 residues in unbound hPRL are best represented by models that have a contribution 
from Rex. The scale of these Rex contributions are ~ 1 s-1, and all but one of the 20 
residues are located in or around areas in helix 1 and 4 considered to be part of the 
HARBS. In hPRL in the binary complex with hPRLR-ECD all the Rex contributions in and 
around the HARBS have been quenched (table 4 and 5), indicating a role for chemical 
exchange in the association of the first hPRLR-ECD to the HARBS, possibly concerning 
recruitment or specificity of the HARBS 
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3.4 Discussion 
3.4.1 Formation	  of	  prolactin	  receptor	  complexes	  
The FPLC size exclusion experiments monitoring hPRL:hPRLR-ECD complex 
formation showed tight binding at the HARBS on hPRL, but wasn’t capable of detecting 
binding at the LARBS on hPRL at the chosen conditions. This observation shows that if 
there is association of hPRLR-ECD to the LARBS, the binding affinity of said association 
has to be much lower than the one at the HARBS.  
The hPRLR-ECD titration of hPRL monitored by 15N-HSQC experiments was capable 
of detecting the formation of both the binary and the ternary hPRL:2hPRLR-ECD 
complex, showing that hPRLR-ECD do interact at the LARBS on wt hPRL in solution. 
The spectra of the titration steps show that the formation of the hPRL:hPRLR-ECD 
complexes are sequential, with full formation of the binary complex before any trace of 
the ternary complex emerges. This observation also suggests widely separated binding 
affinities for hPRLR-ECD at the HARBS and LARBS on hPRL, and we estimated the kD 
of the LARBS to be in the vicinity of 16 µM. Our results unequivocally determines that 
the binding affinities proposed by Sivaparasad et al.53 (kD of HARBS = 100 nM/LARBS = 
150 nM) cannot be accurate, but the results reasonably agree with the binding affinities 
proposed by Jomain et al.55 (kD of HARBS = 3 nM/LARBS = 33 µM).  
The chemical shift changes observed for the backbone amides in wild type hPRL 
observed during the formation of the binary hPRL:hPRLR-ECD complex in the hPRLR-
ECD titration, indicates (ΔCS > 0.45 ppm) a HARBS on hPRL consisting of a region on 
helix 1(V23, S26, H27, H30 and N31), helix 4 (A167, N170, H173, C174, R176, R177, 
D178, S179, H180, K181, D183, K187, K190, R192 and I193), the overhand loop 
between helix 1 and 2 (I51, T52, K53, A54, I55, N56, S57, D68, E70, Q71, N76 and K78) 
and the C-terminal tail (N196, N197, N198 and C199) (Fig. 16C). Minor chemical shift 
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changes throughout the molecule indicate some conformational rearrangement of hPRL 
during receptor biding. The observed HARBS on wild type hPRL, and the possibility of 
structural rearrangement of hPRL upon formation of the binary complex with hPRLR-
ECD agrees well with the observations made by Svensson et al.56 using a crystal 
structure of the binary complex of a truncated prolactin receptor antagonist and hPRLR-
ECD.  
The chemical shift changes caused by formation of the hPRL:2hPRLR-ECD complex 
in the hPRLR-ECD titration suggest that residues in helix 1 (L15, R16, D17, F19, D20, 
V23, V24, L25, H27 and S33), helix 3 (E121, Q122, T123, R125, L126, L127, G129, 
L132, S135 and V137) and the N-terminal tail (I3, C4, G7, R10 and T14) form the 
LARBS on wild type hPRL (Fig. 17B). Chemical shift changes was also observed in the 
C-terminal tail, the c-terminal end of helix 4 and in the overhand loop between helix 1 
and 2, but their location in or adjacent to the HARBS (and distal to the other residues 
suggested for the LARBS) suggest that the chemical shift changes originate from a slight 
rearrangement of the hPRLR-ECD bound to the HARBS due to stem-stem interaction 
with the hPRLR-ECD bound to the LARBS. The lack of chemical shift changes for the 
backbone amides of residues outside the HARBS and LARBS on hPRL upon ternary 
complex formation indicates that the structural conformation of wild type hPRL remains 
unchanged compared to hPRL in the binary complex. Our observations agrees well with 
the observations made using the crystal structure of the ternary complex of affinity 
matured hPRL and two rPRLR-ECD determined by Broutin et al.58. Since the affinity 
matured hPRL has had the N-terminal tail replaced with that of oPL, our observation that 
the N-terminal tail of wild type hPRL is part of the LARBS is of particular interest. 
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3.4.2 Comparison	  of	  dynamic	  parameters	  from	  hPRL	  and	  the	  binary	  complex	  
The model-free analysis of the unbound hPRL revealed a remarkably rigid structure 
with order parameters (S2) generally > 0.9 for residues in the helices, separated by 
highly flexible loops and  (Fig. 18E).   
The NMR relaxation studies of hPRL in the binary hPRL:hPRLR-ECD complex reveals 
significant changes compared to the unbound hPRL (Fig. 18K), especially the first 
overhand loop between helix 1 and 2 (Y44-Q77) and the C-terminal tail (I194-C199) 
have been stabilized and are now on par with the helices in rigidity. This observation fits 
with the report that part of the loop and the C-terminal tail are directly involved in 
receptor binding at the HARBS56.  
3.4.3 Allostery	  driven	  by	  conformational	  entropy?	  
Could the proposed (Sivaparasad et al.53) allosteric effect between the HARBS and 
the LARBS on hPRL be driven by a change in conformational entropy at LARBS upon 
receptor binding at HARBS? 
We have shown that the LARBS consist of residues in helix 1, helix 3 and the N-
terminal tail of hPRL. Due to the high rigidity (high S2 values) of the helices in the 
unbound hPRL, the flexible N-terminal tail is left as the most plausible source of the 
significant entropy change (loss) in the LARBS upon receptor binding at the HARBS on 
hPRL, that is supposed to be driving the proposed allosteric effect. 
The NMR relaxation studies of hPRL in the binary hPRL:hPRLR-ECD complex reveals 
that the first overhand loop between helix 1 and 2 and the C-terminal tail are significantly 
stabilized in the binary complex, but (apart from being part of the HARBS) the loop and 
the tail are located distal to the LARBS, making interactions with LARBS very unlikely. 
No significant changes in S2 are observed for residues in the helices, the second 
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overhand loop between helix 3 and 4 or in the N-terminal tail upon receptor binding at 
the HARBS, effectively removing the possibility of an entropically driven allosteric effect.  
The LARBS residues L25 and Y28, which located on helix 1 adjacent to the HARBS 
residues, experience moderate chemical shift changes during the formation of the binary 
complex, and could possibly provide an alternative explanation for the proposed 
allosteric effect. 
3.4.4 Concluding	  remarks	  
In this study the properties of wild type hPRL-hPRLR-ECD binding in solution has 
been determined, validating observations made in truncated or modified hPRL 
constructs, including the observation by Svensson et al.56 and Broutin et al.58 regarding 
the structure of hPRL in complex with hPRLR-ECD and rPRLR-ECD. 
Furthermore the backbone amide resonances of unbound hPRL and hPRL in the 
binary hPRL:hPRLR-ECD complex have been succesfully assigned, and the model-free 
parameters describing the dynamic properties has been determined. 
Together these observation lead us to dismiss the possibility of an entropically driven 
allosteric effect between the receptor binding sites on hPRL. Any allosteric effect 
increasing the binding affinity at LARBS upon receptor bindging at HARBS must 
therefore derive from other energy sources than entropy. 
4 Paramagnetic Relaxation Enhancement Reveals 
Details of Metal Binding to Prolactin 
4.1 Introduction 
Prolactin (PRL) is a pituitary hormone identified in 1928 by Stricker and Grueter30, who 
showed that PRL stimulates milk secretion in rabbits. PRL is found in all vertebrates and 
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the prolactin receptor (PRLR) (a member of the class 1 cytokine receptor superfamily 
that mediates all of PRL’s biological functions) has been found in a wide variety of 
tissues38. PRL has been shown to play a role in more than three hundred biological 
functions including osmotic regulation, cell proliferation, tumor growth, mammary 
development and lactation38. 
PRL belongs to the growth hormone family that also includes growth hormone (GH) 
and placental lactogen (PL). PRL, like the rest of the growth hormone family, is 
comprised of a four-helix bundle with an up-up-down-down topology (Fig.7). These 
hormones induce dimerization of their cognate receptors through a sequential, two-step 
binding process in which the hormone binds to the extracellular domain of the receptor 
through a high affinity binding site, and subsequently recruits a second receptor to a 
second binding site. Homodimerization of the cognate receptor results in 
phosphorylation of the intracellular domains of the receptor and activation of JAK/STAT 
signalling pathways38.  
4.1.1 Metal	  binding	  in	  the	  Human	  Growth	  Hormone	  family	  
All members of the GH/PRL/PL family have a metal binding site (MBS)78–82, which is 
thought to play a role in the storage of the hormones in secretory granules. High 
concentrations of Zn2+ in the granules may facilitate reversible aggregation of the 
hormones, protecting the hormones against denaturation during storage and nearby 
cells from overstimulation upon hormone release79. It has also been theorized that Cu2+ 
is present in the secretory granules83–85. The reversible aggregation is possibly facilitated 
by structural changes brought about by metal binding86.  
Evidence for the role of metal binding in other biological functions is more equivocal. 
Zn2+ has been shown to be essential for GH and PL binding to the prolactin receptor 
(PRLR), but is not required for GH binding to the growth hormone receptor (GHR) or for 
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PRL binding to the PRLR81,87,88. It is unclear if the actual Zn2+ concentration is high 
enough near the target tissues to facilitate Zn2+ mediated hormone binding to the 
PRLR86. 
4.1.2 Metal	  binding	  site	  on	  the	  human	  Growth	  Hormone	  and	  human	  Placental	  
Lactogen	  
Alanine scanning mutagenesis determined that the MBS on hGH is formed by H18 
and H21 on helix 1 and E174 on helix 4, with E174 being the most important residue79,87 
(Fig. 19). Presence of Zn2+ ions causes dimerization of hGH, and Scatchard analysis of 
equilibrium dialysis showed that Zn2+ binds hGH cooperatively with a 1:1 stoichiometry, 
meaning that there are two Zn2+ ions per dimer, and that the first Zn2+ ion binds hGH with 
a KD of ~1 µM. The mechanism of dimerization remains unclear, since a hGH dimer held 
together with two Zn2+ ions require an additional binding site, but no residues besides 
the H18, H21, E174 MBS are suggested by the alanine scanning mutagenesis to be 
important for dimer formation79.  
The crystal structure of hGH bound to hPRLR (Fig. 20) indicates that a single Zn2+ 
coordinates the MBS on hGH (H18 and E174) and D187 and H188 in hPRLR, mediating 
binding of the receptor, and thus conferring the lactogenic properties of hGH. These 
results also suggest that H21 is not directly involved in Zn2+ coordination, but rather has 
a stabilizing effect on E174 through a hydrogen bond87,89. 
hPL shares 85% sequence identity with hGH, and includes virtually the same MBS 
defined by H18, H21 and E174. Unsurprisingly hPL shares hGH’s metal binding 
properties. Zn2+ causes hPL to dimerize, and the presence of Zn2+ is essential for its 
ability to bind the hPRLR79,81. 
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4.1.3 Metal	  Binding	  Site	  in	  human	  Prolactin	  
Less is known about the MBS of hPRL, but it has been shown that prolactin binds Zn2+ 
and that mutation of H27 (equivalent of H18 in hGH and hPL) decreases hPRL’s ability 
to bind Zn2+78,80. It has also been shown that hPRL binding of hPRLR is independent of 
the presence of Zn2+, which actually lowers the binding affinity for hPRLR88. In further 
contrast to hGH and hPL, which dimerizes in the presence of metals, hPRL forms high-
order aggregates in the presence of moderate concentrations of Zn2+ (more than 10 µM 
of hPRL and Zn2+ respectively)79,80. The residues in hPRL that correspond to the MBS in 
hGH are H27 and H30 on helix 190, and D183 on helix 488, but site-specific metal-
catalyzed oxidation (MCO) (using Cu2+) has suggested that the metal binding site in 
hPRL is comprised of H27 and H30 on helix 1, and H173 on helix 490. The distance 
between the H27, H30 and H173 is so large (16 Å, fig. 21), that metal binding at a site 
comprised of these residues would probably require extensive conformational change88. 
This possibility is supported by a study by Voorhees et al., who observed a change in 
intrinsic fluorescence upon titration of Zn2+ into hPRL solution. Fluorescence changes 
occur when the local environment around tryptophans changes, leading Voorhees et al. 
to conclude that a conformational change occurs in hPRL upon interaction with Zn2+86.   
4.1.4 Metal-­‐mediated	  prolactin	  aggregation	  	  
The role of MBSs on hPRL in metal-mediated aggregation and the role of metal-
mediated aggregation in reversible packing of prolactin in secretory granules has been 
the subject of several studies. Sun et al. showed that hPRL’s ability to bind Zn2+ is 
decreased when H27 is mutated to an alanine, but the amount of metal-mediated 
aggregation is unaffected by that mutation, and they therefore suggested that hPRL has 
two methods of interacting with metals, one at the MBS, and a weaker interaction that 
leads to metal-mediated aggregation80.  
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As proteins pass through the secretory pathway, they experience changes in 
environmental pH. The endoplasmic reticulum has a neutral environment, the trans-
Golgi layer is near pH 6 and finally the secretory granules have a pH value of 5.591–95. 
Sankoorikal et al. 2002 studied hPRL aggregation in solution and in cells, and showed 
that while acidic pH doesn’t affect the solubility of hPRL, metal-mediated aggregation of 
hPRL is dependent on pH. Zn2+ mediated hPRL aggregation in dilute solutions (5 μM 
hPRL) was much less efficient at pH 5.5 than at neutral pH due to protonation of 
histidines hindering Zn2+ coordination96, while Cu2+ coordination (and metal-mediated 
aggregation) is less sensitive to pH changes. Simulating a crowded environment using 
large inert molecules (polyethylene glycol at 90mg/mL) restored the ability of Zn2+ to 
induce aggregates at low pH 85. A H27A hPRL mutant was also studied, where the MBS 
is supposedly incapacitated, and no significant difference in metal-induced aggregation 
was observed between the mutant and wild type hPRL85. The metal-induced prolactin 
aggregates from both wild type hPRL and the mutant hPRL variants turned out to be 
fully solubilized upon metal chelation by addition of EDTA. The reduction of Zn2+ 
mediated hPRL aggregation at low pH and the inability of the H27A mutant to decrease 
metal-induced aggregation led Sankoorikal et al.85 to the conclusion that the MBS 
doesn’t play a significant role in the reversible metal-mediated hPRL aggregation, which 
they, in agreement with the study by Sun et al.80, suggest is caused by low affinity metal 
binding. Using atomic absorption Sankoorikal et al. showed that the metal ion/hPRL ratio 
of the metal-induced precipitates formed in the presence of polyethylene glycol is <1, 
while the ion/molecule ratio in metal-induced precipitates formed in dilute solution are 
>2. Precipitates formed in cells were found to have ion/molecule ratios < 1. Sankoorikal 
et al. conclude that the simulated crowding is the best model for metal-mediated hPRL 
aggregation in cells, and that the low ion/molecule ratio in the precipitate formed in the 
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presence of polyethylene glycol suggests that metal-mediated hPRL aggregation is a 
seeding mechanism for reversible hPRL packing in secretory granules, rather than the 
sole or primary packing mechanism. 
 
To elucidate the mechanism of metal-hPRL interaction this study utilizes titrations of 
the paramagnetic metals Co2+, Cu2+ and Ni2+ into solutions of recombinant wild type 
hPRL monitored by NMR relaxation experiments at pH 7.0 and 5.5. Paramagnetic 
substances speeds up the relaxation rate of nearby nuclear spins in a distance 
dependent manner (r-6)26. This contribution to the relaxation rate is called PRE, and it 
can be measured by standard NMR relaxation experiments26,29, for example the 15N-T1 
relaxation experiment, where the relaxation rate of 15N in backbone amides are 
observed. By measuring the PREs caused by the titration of paramagnetic metals into 
solutions of hPRL we were able to elucidate the interaction between the metals and 
PRL. In addition to PRE studies, we also performed studies of Zn2+ mediated 
aggregation of wild type hPRL, (H27A,H30A,H180A)hPRL and H97A hPRL mutants at 
pH 7.0 and 5.5. Based on our results we are able to unambiguously determine residues 
comprising two MBSs on hPRL and propose a mechanism for metal-induced 
aggregation of hPRL. 
4.2 Materials and methods 
4.2.1 Expression	  and	  purification	  of	  recombinant	  hPRL	  	  
Expression, refolding and purification of recombinant wildtype hPRL and H97A hPRL 
from inclusion bodies were performed using a protocol modified from Teilum et al.47. 
Fully deuterated recombinant wildtype 15N- and 15N,13C-hPRL were expressed in E.Coli 
BL21(DE3) from a pT7-hPRL vector. The bacteria were grown in minimal 2H2O-M9 
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medium containing 15NH4CL and 2H,13C-glucose or 15NH4CL and 2H-glucose as the sole 
nitrogen and carbon sources. The cells were grown at 37 °C until OD600 of 0.9, after 
which protein expression was induced by 1 mM IPTG for 6 hours at 37 °C. After 
harvesting the cells were frozen at -80 °C overnight, resuspended in 50 mM Tris HCl, 0.5 
mM EDTA, 1 mM AEBSF, pH 8.0 and disrupted by sonication. The expressed protein is 
in inclusion bodies, which were washed three times in 10 mM Tris HCl, 1 mM EDTA, pH 
8 and dissolved in 5 M GuHCl, 0.2 M Na2HPO3, 0.2% DTT, pH 7.0 at a protein 
concentration of 0.1 mg/mL. Refolding was performed by dialysis against a 20 mM 
NH4HCO3, 200 mM NaCl, pH 8.0 buffer until the GuHCl concentration < 0.1 M, 
preferably even lower. The sample is then concentrated and purified using a HiLoad 
16/60 Superdex 75 column (GE Healthcare) followed by desalting and final purification 
step using a HiTrap 5mL Q Sepharose HP column (GE Healthcare). To avoid 
contamination with metals, all steps in the refolding and purification protocols can 
include 5 mM EDTA except the last two steps, the desalting and the anion exchange, 
without affecting refolding and purification. As the last step of purification includes 
desalting the sample before the anion exchange column, EDTA is absent in the final 
product. 
Recombinant 15N-H97A hPRL was expressed in E.Coli BL21(DE3) from a pT7 vector. 
The bacteria were grown in minimal M9 medium containing 15NH4CL as the sole nitrogen 
source. The cells were grown at 37 °C until OD600 of 0.9, after which protein expression 
was induced by 1 mM IPTG for 3 hours at 37 °C. The purification protocol used for H97A 
hPRL was identical to the one used for wild type hPRL. 
Unlabelled recombinant (H27A,H30A,H180A)hPRL was kindly provided by Dr. Michael 
Hodsdon, Yale University.  
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4.2.2 NMR	  instrumentation	  	  
All NMR spectra were recorded on a Varian/Agilent VNMRS 600 instrument (14.1 T) 
equipped with a 5 mm HCN inverse cold probe with z-axis gradient. 
4.2.3 NMR	  resonance	  assignments	  
Assignments of hPRL backbone 15N, 13C and 1H resonances are known at pH 8, 37 
°C47,	  where 138 of 199 residues have been assigned. At pH 7.0 these known 
assignments were complemented by 15N-HSQC 60, HNCO 61–64, HNCACB63–65 and 
HNCACO66 experiments from the Biopack library (Varian/Agilent) of a 400 µM 
deuterated 15N,13C-hPRL, 50 mM KPO4, 10% D2O, 0.02% NaN3, pH 7.0 sample at 35 °C 
in order to assign additional resonances that appear due to the slower amide exchange 
at pH 7.0. 
In order to assign the 15N and 1H backbone resonances of hPRL at pH 5.5, a pH 
titration using 15N-HSQC’s of hPRL at pH 7.0, 6.5, 6.0 and 5.5 was performed. 
 The 15N-HSQC, HNCO, HNCACB and HNCACO experiments were processed with 
the Rowland NMR Toolkit and analyzed with NMRViewJ68. 
4.2.4 NMR	  relaxation	  studies	  of	  hPRL	  
A 15N-T1 relaxation experiment 69,70 from the Biopack library (Varian/Agilent) of 200 µM 
deuterated 15N-hPRL, 20 mM MOPS, 20 mM NaCl, 10% 2H2O, pH 7.0 at 35 °C was 
recorded to obtain the relaxation rates of the 15N spins from the backbone amides in 
hPRL. The recombinant hPRL was refolded in the presence of the metal chelating agent 
EDTA to ensure that there was no metal contaminates the sample. The 15N-T1 
experiments were processed by VnmrJ (Varian/Agilent) and NMRPipe71, and the curve 
fitting and error calculation was done by MUNIN72. 
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4.2.5 NMR-­‐monitored	  metal	  titration	  
Metal titrations (Co2+, Cu2+, Ni2+ and Zn2+) monitored by 15N-HSQC and 15N-T1 
relaxation experiments from the Biopack library (Varian/Agilent) were utilized to 
determine and characterize the MBS on hPRL. Low protein concentrations of 100 µM 
and 200 µM hPRL are used in the metal titrations to avoid substantial metal-mediated 
hPRL aggregation, and 20 mM MOPS, 20 mM NaCl, pH 7.0 and 10 mM MES, 20 mM 
NaCl, pH 5.5 buffers are used to avoid phosphate mediated metal aggregation. 
Each titration step involved the rapidly mixing of 4 µL concentrated metal solution in 
MOPS or MES buffer into the 600 µL NMR sample. The concentration of the metal 
solution was calculated so that the final metal/protein concentration ratio took the 
increase in total sample volume into account. The PREs of individual hPRL residues was 
determined by subtracting the R1 rates of hPRL with no paramagnetic metal present 
from the hPRL R1 rates recorded in the presence of paramagnetic metals. 
4.2.6 Metal-­‐induced	  hPRL	  aggregation	  
In order to assay the amount of metal-mediated hPRL aggregation, 50 µL samples of 
25 µM wild type hPRL, (H27A,H30A,H180A)hPRL and H97A hPRL in either 20 mM 
MOPS, 20 mM NaCl, pH 7.0 or 10 mM MES, 20 mM NaCl, pH 5.5 was incubated with 
Zn2+ as indicated for 15 minutes (table 6 and 7). The samples were then centrifuged for 
30 minutes at 16000g, and the protein concentration in the top 20 µL was measured by 
A280 on a NanoDrop 1000 (Thermo Fisher Scientific) spectrophotometer. Each point is 
the average of duplicate samples and the error bars represent the range. 
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4.2.7 Estimation	  of	  the	  kD	  for	  hPRL-­‐Cu2+	  binding	  
It is possible to estimate the theoretical PRE arising from fully saturated Cu2+ binding 
to hPRL using The Solomon-Bloembergen equations27,28,97,98, which gives the expression 
for the R1 of 15N spins affected by PRE (R1P) seen in equation (49). 
Assuming fast exchange between the bound and unbound state for hPRL and Cu2+, 
the observed R1 rates 𝑅!!"#  can be described by the contributions from the populations 
of Cu2+ bound (paramagnetic) hPRL and unbound (diamagnetic) hPRL 26:  𝑅!!"# = 𝜎!𝑅!! + 𝜎!𝑅!!                     52  1 = 𝜎! + 𝜎!                                           53  
where 𝜎!and 𝜎! are the populations of the diamagnetic and paramagnetic states. 
With 𝑅!! known from the 15N-T1 relaxation experiments of hPRL without Cu2+, 𝑅!!"# known 
from the 15N-T1 relaxation experiments of hPRL with Cu2+, and an estimation of 𝑅!! it is 
possible to estimate the populations of metal bound and unbound hPRL: 𝑅!!"# = 𝑅!! 1 − 𝜎! + 𝑅!!𝜎!             54  
𝜎! = 𝑅!!"# − 𝑅!!𝑅!! − 𝑅!!                                                  55  
with both 𝜎! and 𝜎! known, it is possible to estimate the kD of Cu2+ binding to the 
MBSs on hPRL: 
𝑘! = 𝐶𝑢 ℎ𝑃𝑅𝐿𝐶𝑢: ℎ𝑃𝑅𝐿                                                                                                                56  
𝑘! = 𝐶𝑢! − ℎ𝑃𝑅𝐿! ∗ 𝜎! ℎ𝑃𝑅𝐿! ∗ 𝜎!ℎ𝑃𝑅𝐿! ∗ 𝜎!                      57  
where hPRL0 is the original hPRL concentration and Cu0 is the original Cu2+ 
concentration. 
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4.2.8 Estimating	  the	  position	  of	  the	  Cu2+	  ion	  bound	  to	  hPRL	  
The r-6 distance dependence of PREs can seen in equation (49), and since the 
magnetic moment of unpaired electrons is very high compared to that of protons, PREs 
can, in contrast to NOEs, be observed through long distances (up to 35 A)26. PREs are 
thus commonly used to determine long range distance restraints from paramagnetic 
tags, which are then used to refine calculated structures. In our case we want to reverse 
this process by using observed PREs in a known structure to estimate the position of the 
coordinated paramagnetic metal. Our data consists of R1 nitrogen relaxation rates, which 
causes some complications. Usually proton relaxation is used for the generation of 
distance restraints due to the higher magnetic moment of protons compared to that of 
nitrogen, and low PREs of R1 relaxation has a tendency to be exaggerated compared to 
the actual distances due to solvent interactions26. In our case the observed PREs are 
relatively weak (>5 s-1) due to the nitrogen relaxation and a relatively low binding affinity. 
It is thus expected that a fair amount of error is involved, and so only the strongest PREs 
should be used to generate the distance restraints, and those restraints should have 
generous flexibility. By combining these restraints with the twenty solution structures of 
hPRL 47 it is possible to estimate the Cu2+ position that best fits the measured PRE 
profile by performing a least squares minimization. To perform the minimization we 
utilized MoSART, a NMR-based biomolecular structure computation program99,100.  
4.3 Results 
4.3.1 Assigning	  NMR	  resonances	  in	  hPRL	  
Using 15N-HSQC, HNCO, HNCACB and HNCACO experiments we successfully 
assigned an additional 35 of hPRL’s backbone amides at pH 7.0, bringing the total from 
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138 assigned by Teilum et al.47 to 173 out of 199, or 87%. It was possible to assign 152 
of hPRL’s backbone amides at pH 5.5 using pH titration.  
4.3.2 R1	  relaxation	  rates	  of	  hPRL	  refolded	  in	  the	  presence	  of	  EDTA	  
The 15N-T1 relaxation experiment of recombinant hPRL refolded in the presence of 
EDTA at pH 7.0 allowed the extraction of R1 relaxation rates of 145 out of hPRL’s 173 
assigned backbone amide 15N spins (Fig. 18A). It was not possible to extract the 
remaining 28 R1 rates due to overlapping resonances and line broadening from fast 
amide exchange. 
At pH 5.5 it was possible to extract 126 out of hPRL’s 152 assigned backbone amide 
15N spins 
4.3.3 Zn2+	  titration	  of	  hPRL	  at	  pH	  7.0	  
Zn2+ is one of the metals thought to be involved in the packing of hPRL and other 
hormones in the GH/PRL/PL family in secretory granules 78,79. A Zn2+ titration series was 
performed in an attempt to directly observe Zn2+ binding. Diamagnetic Zn2+ causes no 
PRE, but any metals binding to a protein causes the local environment of the involved 
residues to be altered, resulting in chemical shift changes for the NMR signals of the 
residues near the metal. Due to metal-mediated aggregation Zn2+ titration was only 
possible in very dilute hPRL samples (20 μM). Even under these conditions Zn2+:hPRL 
molar ratios greater than 1:1 resulted in visible precipitates forming, and no significant 
chemical shift changes were observed during the Zn2+ titration. Significant reductions of 
the hPRL signals occured even before precipitation were visible, indicating metal-
mediated self-association of hPRL into soluble aggregates. 
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4.3.4 Titration	  of	  hPRL	  with	  paramagnetic	  metals	  at	  pH	  7.0	  
Preliminary titrations of the paramagnetic metals Co2+, Cu2+ and Ni2+ to a metal:hPRL 
ratio of 0.5:1 at pH 7.0 were performed to identify a suitable paramagnetic metal for 
studying binding of metals to hPRL. The titrations were monitored by 15N-T1 relaxation 
experiments and showed PREs affecting the same residues for all three paramagnetic 
metals. Cu2+, which is the second metal theorized to be present in secretory granules83–
85, produced the most pronounced PREs (Fig. 22). Cu2+ titrations, monitored by both 15N-
HSQC and 15N-T1 relaxation experiments, were performed at pH 7.0 with metal:hPRL 
ratios of 1:1, 2:1 and 4:1 to explore the PRE’s dependence on metal concentration. In 
order to avoid excessive metal-mediated aggregation, the hPRL concentration in the 4:1 
Cu2+:hPRL titration step was lowered to 100 µM.  
No significant chemical shift changes are observed in the 15N-HSQC experiments 
monitoring the Cu2+ titration series, indicating that no structural changes take place in 
hPRL upon association with metals. The resonance corresponding to H180 undergoes 
significant PRE associated line broadening in the Cu2+ titrations (Fig. 23), and is 
rendered undetectable at a Cu2+:hPRL ratio of > 1:1. H46, T52, K53, H97 and H173 are 
also line broadened, although to a lower degree than H180, indicating interactions with 
soluble Cu2+. At the Cu2+:hPRL ratio of 4:1 metal-mediated self-association sets in, 
causing ~ 40% intensity loss of all 15N-HSQC signals across all resonances. Since 
visible aggregation minimally apparent, significant soluble aggregates must be present in 
the sample. The lineshape of the 15N-HSQC signals remains unchanged, and no new 
signals appear, indicating that the size of the soluble aggregates renders them invisible 
in 15N-HSQC spectra due to size dependent line broadening. 
The 15N-T1 relaxation experiments show that the PREs build up with increasing 
amounts of Cu2+ (data not shown), with the largest PREs observed in the 4:1 Cu2+:hPRL 
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titration step (Fig. 24). The hPRL residues most affected by the metal-mediated PREs 
are H26-S34 in helix 1 and R176- D183 in helix 4, a cluster of residues in a region 
spanning the middle of the two adjacent α-helices (Fig. 25A). The residues with the 
largest PREs (> 1.4 s-1 in the 4:1 Cu2+:hPRL titration step) are H27, H30, N31, S34, 
R177, H180 and D183. H180 is broadened beyond detection at Cu2+:hPRL ratios above 
1:1, resulting in the large error observed. The solution structure of hPRL shows that the 
three histidines, H27, H30 and H180, are positioned favorable for metal coordination 
with distances between their imidazole rings between 4 and 6 Å (Fig. 26)47, suggesting 
that they form a MBS (Fig. 25C).  
Weaker PREs can be seen at residues E93, Y96, H97, E101 and W150 (Fig. 25B), 
with the most pronounced PREs observed for E93 and H97, indicating a possible MBS 
located on the opposite side of hPRL compared to the proposed H27, H30, H180 MBS 
(Fig. 25D and 27). This secondary MBS could play a role in metal-mediated aggregation 
of hPRL. H46 and H173 are, like H180, broadened beyond detection, but due to very low 
initial signal intensity, this observation doesn’t necessarily indicate strong interaction with 
Cu2+.  
The sample from the 4:1 Cu2+:hPRL titration step was diluted by half (50 µM hPRL, 
200 µM Cu2+) and a 15N-T1 relaxation experiment was performed in order to elucidate if 
the PREs arise from interactions to metals in solution or to metals tightly bound to other 
hPRL molecules. The PREs observed in the diluted sample was of a magnitude 
comparable to those in the undiluted sample (Fig. 28), indicating that the PREs arise 
from low affinity contact to paramagnetic metals in solution. 
4.3.5 Chelation	  of	  metal:hPRL	  samples	  at	  pH	  7.0	  by	  EDTA	  
The indication of low affinity metal binding to hPRL is supported by observation that 
addition of a two-fold excess of EDTA to Cu2+ to a sample with a Cu2+:hPRL ratio of 4:1 
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results in drastically decreased PREs (Fig. 29), and that addition of excess EDTA 
(2*Cu2+ concentration) to insoluble hPRL aggregates results in complete resolubilization 
of the precipitates. However weak PREs are still observed in metal containing hPRL 
samples after addition of EDTA, indicating that the Cu2+ ions chelated by EDTA can still 
interact with hPRL through a single coordination site, either through displacement of one 
of EDTA’s carboxylate arms or through seven-ligand coordination101. To ascertain that 
the residual PREs were not the result of un-chelated Cu2+ ions (even though the 
Cu2+:EDTA kD of 1.66*10-17 M at pH 7.0 makes it unlikely), further excesses of EDTA 
was added (up to 20-1 EDTA:Cu2+ ratio) with no resulting PRE changes (data not 
shown), and 15N-HSQC experiments of EDTA chelated hPRL:Cu2+ samples shows that 
the signals from H46, T52, K53, H97, H173 and H180 are line broadened, H180 beyond 
detection, even though all other signals are restored to pre-Cu2+ titration intensities. 
Desalting the EDTA chelated hPRL:Cu2+ sample on a size exclusion column, effectively 
removing all EDTA, resulted in the last residual PREs disappearing in the 15N-T1 
relaxation experiments (Fig. 30), and caused the 15N-HSQC signals for H46, T52, K53, 
H97, H173 and H180 to regain their pre-titration intensities. 
4.3.6 Cu2+	  titration	  of	  hPRL	  at	  pH	  5.5	  
Since the environment in secretory granules has a pH around 5.5, the metal binding 
properties of hPRL at this pH were investigated using 15N-T1 relaxation experiments. 
Since the 2:1 Cu2+:hPRL ratio did not result in significant aggregation at pH 7.0, a 100 
µM hPRL, 200 µM Cu2+ sample was examined first. The sample completely precipitated, 
showing that Cu2+ mediated aggregation is much more efficient at pH 5.5 than at pH 7.0. 
A second sample was prepared at a Cu2+:hPRL ratio of 0.3:1, which exhibited no visible 
hPRL precipitation, and a 15N-T1 relaxation experiment was performed. The measured 
PREs can be seen in figure 31, showing pronounced PREs (>1 s-1) at the H27, H30, 
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H180 MBS, and equally large PREs at the E93 and H97 MBS. PREs of that magnitude 
for such a low Cu2+:hPRL ratio indicate significantly increased affinity for Cu2+ at both 
sites at pH 5.5, and the fact that the PREs at the E93, H97 MBS equal the ones 
observed for the H27, H30, H180 MBS indicates that the raised affinity for Cu2+ at the 
E93, H97 MBS plays a significant role in the more efficient Cu2+ mediated hPRL 
aggregation at pH 5.5. 
4.3.7 Metal-­‐induced	  hPRL	  aggregation	  
In an effort to determine the role of the H27, H30, H180 MBS and the E93, H97 MBS 
in metal-mediated aggregation and Zn2+ coordination, a study using A280 measurements 
of wt hPRL, H97A hPRL and (H27A, H30A, H180A)hPRL to determine the amount of 
protein still in solution after titrations of Zn2+ were performed at pH 7.0 and pH 5.5 (Fig. 
32A). The results show that Zn2+ efficiently aggregates wt hPRL at pH 7.0, with ~50% of 
the hPRL aggregated at a Zn2+:hPRL ratio of 1:1. Completely disrupting the primary H27, 
H30, H180 MBS significantly impairs the ability of Zn2+ to induce hPRL aggregation, with 
the mutant requiring a Zn2+:hPRL ratio of 4:1 to aggregate ~50% of hPRL at pH 7.0, 
showing the importance of the H27, H30, H180 MBS in metal-mediated aggregation and 
Zn2+ coordination. Impairing the secondary binding site by mutating H97 gave similar 
results (Fig. 32B). At pH 5.5 the ability of Zn2+ to mediate wt hPRL aggregation is 
significantly impaired compared to pH 7.0, requiring a Zn2+:hPRL ratio of 4:1 to 
aggregate ~50% of the protein, while the (H27A, H30A, H180A)hPRL mutant effectively 
doesn’t aggregate in the presence of Zn2+ at pH 5.5, requiring 4 mM Zn2+ to aggregate 
~50% of the 25 μM protein. The H97A hPRL mutant show slightly lowered propensity for 
Zn2+ mediated aggregation compared to wt HPRL (Fig. 32B), but the small magnitude of 
the difference makes the significance uncertain. The small difference in Zn2+-mediated 
aggregation at pH 5.5 observed between wt hPRL and H97A hPRL could be explained 
 
 
64 
by the decreased importance of histidines as metal coordinating residues at low pH due 
to protonation, and that E93 is still present in the mutant. 
4.3.8 Estimation	  of	  the	  kD	  for	  hPRL-­‐Cu2+	  binding	  
In order to calculate an estimate of the binding affinity of the Cu2+ ion for hPRL, 
equation (52) was used to calculate the theoretical PRE of the R1 relaxation rates in 
hPRL fully saturated by Cu2+ ions. In order to carry out this calculation, it was assumed 
that the ion factor for Cu2+ was 2.0 and that the electronic relaxation time 𝜏! has a value 
of 1.3 ns. The rationale behind the assumption is that Cu2+ binding sites with tetragonal 
have 𝜏! values in the 1.0-10.0 ns  range102, and a study of a similar Cu2+-protein 
interaction found a 𝜏! of 1.3 ns 29. Combined with a 𝜏! for hPRL of 13.34 ns, which was 
estimated from the R2/R1 ratios (results not shown), this estimate resulted in a 𝜏! value 
of 1.18 ns. 
It was furthermore assumed, that the distance between the backbone amide nitrogen 
of the central coordinating residue, H180, and the Cu2+ ion is similar to the distance 
between the Zn2+ ion and H18 observed in the crystal structure of the hGH-hPRLR 
complex, 5.3 Å 89. Together these assumptions allowed us to estimate that in a magnetic 
field of 14.1 T (600 MHz), the theoretical R1P of H180 in a hPRL sample fully saturated 
with Cu2+ would be 33.65 s-1. 
At pH 7.0 the signal for H180 linebroadened beyond detection during the Cu2+ titration, 
but for a 100 µM hPRL sample at pH 5.5 titrated with 30 µM Cu2+, the R1obs for H180 in 
hPRL is 2.94 s-1, while the R1D is 1.01 s-1. Using equation (6) this results in a 𝜎! of 0.06, 
which again, using equation (8) allows us to estimate that the kD of the Cu2+ interaction 
with the H27,H30,H180 metal binding site is in the order of ~375 µM. This estimation 
could seem a little low since a 100 µM hPRL sample completely aggregates at a 200 µM 
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Cu2+ concentration, but this observation could be due to the aggregation removing the 
soluble protein from the equilibrium. 
4.3.9 Estimating	  the	  position	  of	  the	  Cu2+	  ion	  bound	  to	  hPRL	  using	  observed	  PREs	  
The Cu2+-mediated PREs of hPRL recorded at pH 5.5 (Fig. 31) were used in this 
estimation, since the Cu2+ affinity is highest at that pH and no residues are 
linebroadened beyond detection. PREs stronger than 0.85 s-1 were used to generate a 
list of restraints for the distance between the Cu2+ ion and the backbone amide nitrogen 
of the selected residues. 
The distance restraints between residues in hPRL and the Cu2+ ion was generated by 
assuming that the strongest observed PRE (that of H180) corresponds to a distance of 5 
Å, an assumption supported by the observed distance (5.3 Å) for Zn2+ binding in the 
similar MBS on hGH89. The distance restraints for the remaining residues were set using 
the K1 value (equation 49) calculated for H180’s PRE corresponding to 5 Å. Utilizing 2 Å 
uncertainties, the restraints generated can be seen in table 8. 
Least square minimizations performed on the full list of distance restraints did not 
converge and resulted in estimated Cu2+ positions in the hydrophobic core of the hPRL 
molecule with multiple large distance violations (> 10 Å, data not shown), demonstrating 
that the Cu2+ mediated PREs originate from two distinct MBSs on hPRL.  
After splitting up the restraints into two groups centered around H27, H30, H180 and 
E93, H97, the least square minimizations performed with the restraints from the H27, 
H30, H180 MBS on the twenty solution structures47 of hPRL (Fig. 33A) all converged, 
showing estimated Cu2+ ion positions grouped in close proximity to the side chains of 
H30 and H180. Of the twenty least square minimization performed with the restraints 
from the E93, H97 MBS on the solution structures47 of hPRL (Fig. 33B), sixteen 
converged with estimated Cu2+ ion positions in two groupings, one located close to the 
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sidechain of H97, and one located between the sidechains of E93 and H97. The energy 
levels of the minizations were an order of magnitude higher for the E93, H97 MBS 
compared to the H27, H30, H180 MBS. 
4.4 Discussion 
The titration of paramagnetic metals identified a cluster of residues, H27, H30, N31, 
S34 on helix 1 and R177, H180 and D183 on helix 2 (Fig. 25A) in hPRL as experiencing 
the most pronounced PREs. Of these residues H180 is the most affected, indicating a 
central importance to the MBS on hPRL. Histidines, which play a central role in many 
types of metal binding sites on proteins, have an imidazole side chain that can 
coordinate metal ions, including Co2+, Cu2+, Ni2+ and Zn2+. Previous studies have 
suggested that H27 and H30 are important for hPRL’s ability to bind metal ions80,90, and 
H27, H30 and H180 are positioned to create a MBS, which closely resembles the hGH 
MBS (Fig. 25C)79. Furthermore we identified a secondary MBS at E93 and H97, which 
showed low affinity for Cu2+ at pH 7.0, but rivaled the binding affinity for Cu2+ of the H27, 
H30, H180 MBS at pH 5.5 (Fig. 25D). Both binding sites were shown to be important for 
metal-mediated aggregation, as raised affinity for Cu2+ at these sites at pH 5.5 correlated 
with increased propensity for metal-mediated aggregation, and hPRL mutants without 
the primary MBS (H27A,H30A,H180A hPRL), or with an impaired secondary MBS (H97A 
hPRL) showed significantly decreased Zn2+ mediated protein aggregation at pH 7.0 (Fig. 
32A). At pH 5.5 the lack of the H27, H30, H180 MBS disrupts Zn2+ mediated protein 
aggregation, while the impaired E93, H97 MBS doesn’t affect the aggregation to the 
same degree (Fig. 32B), possibly because the strongest binding partner for Zn2+ at pH 
5.5 (E93) still is present. Based on these observations we conclude that both binding 
sites are capable of coordinating both Zn2+ and Cu2+ (the H27, H30, H180 MBS are also 
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capable of coordinating Ni2+ and Co2+, albeit with lower affinity) and that both binding 
sites are critical for metal-induced hPRL aggregation.   
Our estimation of the Cu2+ ion position in the primary MBS (Fig. 33A) suggests that the 
metal coordinating residues are H30 and H180. The long distance between the side 
chain of H27 (> 6Å) and the Cu2+ ion, together with the observation that alanine 
mutagenesis of H27 affects the ability of hPRL to coordinate Zn2+80, but doesn’t affect 
metal-mediated hPRL aggregation80,85, indicates a possible role for H27 stabilizing the 
primary MBS. Thus the properties of the primary MBS on hPRL closely resemble those 
of the MBS on hGH, which has been shown to coordinate Zn2+ directly from two residues 
in the MBS on hGH (H18 and E174) and two residues in hPRLR, D187 and H188 in 
hPRLR, forming an intermolecular bridge (Fig. 20), while the third residue in the MBS on 
hGH (H21) served as a stabilizing factor. Another possibility is that H27 on hPRL directly 
coordinate metals when the metal only binds one hPRL molecule, which would explain 
why mutations of H27 decreases Zn2+ binding in dilute systems80. Since the H27, H30, 
H180 MBS on hPRL consists of three residues, a fourth ligand site remains a 
speculative possibility, potentially fulfilled by any amide or carboxylate group. The 
estimation of the Cu2+ ion position in the E93, H97 MBS indicates a much less ordered 
interaction with the metal ion, possibly with different numbersof possible metal-
coordinating residues (one or two) (Fig. 33B). This observation is consistent with the 
finding from the Zn2+ aggregation studies. 
Based on our results we propose a mechanism for metal-mediated aggregation of 
hPRL that involves metal bridging between the hPRL molecules (Fig. 27B). Zn2+ and 
Cu2+ generally coordinate four ligands103, leading us to suggest that H30 and H180 in the 
primary MBS on hPRL coordinates an intermolecular metal bridge to two residues in 
either the primary (H27, H30, H180) or secondary (E93, H97) MBS on another hPRL 
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molecule (Fig. 27A), resulting in the formation of large protein aggregates (Fig. 27B), but 
other combinations of metal coordinating residues are also possible (H27, H30, H180 to 
E93 or H27, H30, H180 to H97). 
The proposed H27, H30, H180 and E93, H97 MBSs, with inter-imidazole ring 
distances of ~ 4-6 Å, don’t require hPRL to undergo conformational changes upon 
interaction with metals as hypothesized by Sandineni et al. and Voorhees et al.86,90 and 
we see no evidence for substantial metal-mediated conformational changes in our 
studies. An alternative interpretation of Voorhees et al.’s observations is that the Zn2+ 
induced intrinsic fluorescence changes could originate from metal-mediated aggregation 
instead of conformational changes in hPRL. One of the two tryptophans in hPRL (W150) 
is solvent exposed47 and located next to the secondary MBS at E93 and H97, which we 
show are important for metal-mediated hPRL aggregation. Binding of a metal and 
possible metal-mediated association of hPRL molecules would perturb the environment 
around the tryptophan, resulting in intrinsic fluorescence changes. Voorhees et al. don’t 
observe Zn2+ mediated fluorescence changes in hGH, where the only tryptophan is 
buried in the core of the protein104, reducing the likelihood of intrinsic fluorescence 
changes due to metal-mediated dimerization. 
The 15N-HSQC signals for H46, L52, K53 and H173 are broadened during Cu2+ 
titration, but due to their low initial signal intensity it was hard to extract R1 rates from 
these residues at pH 7.0, but at pH 5.5 no significant PREs are observed for these 
residues. It is thus likely that the line broadening of these residues are due to transient 
interactions of a solvent-exposed imidazole ring with soluble Cu2+ instead of actual metal 
binding. Lysine and leucine aren’t normally associated with metal coordination but L52 
and K53 are located in the first overhand loop, where the flexibility allows the residues to 
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come into close proximity of H173, where the transient Cu2+ population can cause the 
observed line broadening in the 15N-HSQC spectra.  
Our proposed mechanism for hPRL aggregation offers potential insights into the 
behavior of hGH in the presence of Zn2+. hGH doesn’t undergo Zn2+ mediated 
aggregation, but dimerizes instead79. hGH has a cluster of glutamic acids, E29, E30, 
E32 and E33 on helix 1 (Fig. 27C)104, that potentially could have a role equivalent of the 
E93, H97 MBS on hPRL. The E29, E30, E32, E33 cluster on hGH is located next to the 
H18, H21, E174 MBS instead of one the opposite side of the molecule as is the case in 
hPRL. Metal bridging of the MBS on one hGH molecule and the E29, E30, E32, E33 
cluster on another hGH molecule could result in a tight hGH “sandwich” held together by 
two Zn2+ ions (Fig. 27D), which would fit the properties of the hGH dimer described by 
Cunningham et al.79. The cluster would also explain why single spot alanine mutations 
couldn’t identify this potentially important region for hGH dimerization, since knocking out 
a single glutamic acid probably has negligible effect upon the metal binding properties.  
The Cu2+ titration also provides insight into the binding properties of the two MBSs on 
hPRL. Tight binding of a paramagnetic metal to hPRL would simply result in the loss of 
detectable signal from residues in close proximity (< 5 Å) to the metal, due to the 
powerful PRE-induced line broadening. The 15N-T1 relaxation experiments would show 
no observable PRE of the residues directly involved in the MBS, since all the 
measurable R1 rates would originate from hPRL not bound to the paramagnetic metal, 
but residues at further distances would experience PRE. The clustering of the residues 
experiencing PRE and the absence of long-range PREs makes tight binding highly 
unlikely, but alternatively the observed PREs could originate from Cu2+ ions tightly bound 
to the MBS of hPRL affecting residues on other hPRL molecules, but then the observed 
PREs would be expected to decrease with protein concentration, as transient Cu2+ 
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encounters would diminish. Dilution of hPRL (from 100 µM to 50 µM) in the final step of 
the Cu2+-titration did not affect the magnitude of the PREs observed by 15N-T1 relaxation 
experiments, indicating that Cu2+ is not tightly bound, but in fast exchanges between the 
bound state and the solution. Using an estimated distance of 5.3 Å between the Cu2+ 
and the backbone amide, we were able to estimate the binding affinity for both MBSs on 
hPRL at pH 5.5 for Cu+ to be approximately 375 µM.  
4.5 Conclusion 
We conclusively demonstrate that hPRL has a primary MBS consisting of H27, H30 
and H180 and a secondary MBS consisting of E93 and H97, neither of which requires 
structural changes upon metal binding. Following from determination of the two MBSs on 
hPRL, and the observation that disrupting either MBS severely restricts metal-mediated 
aggregation, we propose a mechanism for metal-mediated aggregation by 
intermolecular metal bridging between the MBSs on hPRL. This self-association 
mechanism allows the formation of large amorphous aggregates, which agrees with 
previous observations of Zn2+ mediated high-order aggregates79,80. Finally, the 
observation that metal chelation by EDTA facilitates full resolubilization of metal:hPRL 
precipitates, which was initially reported by Sankoorikal et al.85, supports the role of the 
MBS on hPRL in efficient, reversible packing of hormones in secretory granules. The 
role of H180 in metal binding and in pH-dependent regulation of PRL activity105 suggests 
the possibility of thermodynamic coupling between pH and metal regulation of PRL 
stability and activity. Neglect of this possibility could well be responsible for some 
inconsistencies in the literature. Future investigations of the joint influence of H+ and 
metal ions on PRL activity should reveal additional insights into regulation of PRL 
secretion and function. 
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5 Abbreviations 
FPLC : Fast Protein Liquid Chromatography 
Full-oPL-Nter : full ovine placental lactogen N-terminal tail 
GH : growth hormone 
GHR : growth hormone receptor 
HARBS: high affinity receptor binding site 
LARBS : low affinity receptor binding site 
MBS : metal binding site 
NOE : nuclear overhauser effect 
PL : placental lactogen 
PRE : paramagnetic relaxation enhancement 
PRL : prolactin 
PRLR : prolactin receptor 
PRLR-ECD : extracellular domain of the prolactin receptor 
R1 : longitudinal relaxation rate or spin-lattice relaxation rate 
R2 : transverse relaxation rate or spin-spin relaxation rate 
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6 Figures 
 
 
Figure 1: Magnetic moment of spin ½ nuclei in an external magnetic field 
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Figure 2: Spin ½ nuclei aligning with or against an external magnetic field B0 
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Figure 3: Precession of spin ½ nuclei around B0 
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Figure 4: Relationship of T1 and T2 times with the overall correlation time of the molecule. T1 decreases with 
increasing size and viscosity until the 1/ν0 limit, then it increases again. In contrast, T2 continuously 
decreases with increasing size and viscosity 
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Figure 5: Two spin system (S + I) of spin ½ nuclei with transition probabilities W between the high energy 
state β and the low energy state α. Wα and Wβ are single quantum transitions, W0 is a zero quantum 
transition and W2 is a double quantum transition. 
 
 
 
 
 
  
 
 
77 
 
Figure 6: Relationship of NOE to the overall correlation time τm. Large molecules get negative NOEs and 
small molecues get positive NOEs 
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Figure 7: NMR structure of hPRL (PDB entry 1RW5)47 showing the secondary structure. Helix 1 is red, helix 
2 is orange, helix 3 is azure, helix 4 is blue, the disulphide bridges are yellow, and the short 310-helix (H1’) 
and α-helix (H1’’) in the first overhand loop are green. 
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Figure 8: HARBS on hPRL as indicated by alanine scanning mutagenesis (V23, H27, H30, F37, H59, P66, 
K69, Y169, H173, R176, R177, H180, K181, N184, Y185, K187 and L188) 
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Figure 9: LARBS on hPRL as indicated by alanine scanning mutagenesis (L18, R21, A22, L25, Y28, R125, 
L126, E128, G129, L132 and I133) 
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Figure 10: Crystal structure of prolactin receptor antagonist Del1-9-(C11S)G129R-hPRL (green) in complex 
with hPRLR-ECD (magenta), obtained from PDB entry 3D4856  
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Figure 11: Important binding motif for the HARBS on hPRL and hPRLR-ECD. K69 stacks with W139R from 
hPRLR-ECD and forms an ion pairing network: K66R-E18R-K69-D134R-K136R 
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Figure 12: Important binding motif for the HARBS on hPRL and hPRLR-ECD. R177 on helix 4 interacts 
directly with hPRLR-ECD residues E43R, T74R and D96R and indirectly through water with D96R and T98R. 
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Figure 13: Crystal structure of affinity matured antagonist (Full-oPL-Nter)hPRL (green) in complex with two 
rPRLR-ECDs obtained from PDB entry 3EW358. The HARBS bound receptor (magenta), and the LARBS 
bound receptor (orange).  
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Figure 14: 15N HSQC of 200 µM deuterated hPRL in 20 mM MOPS, 20 mM NaCl, pH 7, 35 °C at 600MHz. 
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Figure 15: hPRL:hPRLR-ECD complex formation monitored by size exclusion FPLC using a HiLoad 16/60 
Superdex 75 column. The graph from the 1:1 hPRL:hPRLR-ECD (12 µM/12 µM) is colored blue, the 1:2 (6 
µM/12 µM) mixture is red and the 1:4 (3 µM/12 µM) mxture is green. 
  
 
 
87 
 
Figure 16: Receptor binding at the HARBS on hPRL.   
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16A: Titration step 1 through 3 (table 3) in the hPRLR-ECD titration of hPRL monitored by 15N-HSQC at 
pH7, 35 °C, 600 MHz. The HSQC spectrum of the 1:0.33 hPRL:hPRLR-ECD concentration ratio is blue, the 
1:0.66 spectrum is green and 1:1 spectrum is red. Residue S26 is part of the HARBS on hPRL, and the 1D 
traces show the development of peak intensity during the hPRLR-ECD titration. Q122 and G129 are part of 
the LARBS on hPRL, and G104 is distal to both binding sites.  
16B: Chemical shift change (ΔCS) for hPRL resonances upon binding of a hPRLR-ECD at the HARBS 
recorded at pH7, 35 °C, 600 MHz. 𝚫𝑪𝑺 = 𝚫𝜹𝑯 𝟐 + 𝟎.𝟏𝚫𝜹𝑵 𝟐, where ΔδH is the proton chemical shift 
change and ΔδN is the nitrogen chemical shift change. Green boxes represent the four α-helices.  
16C: The solution structure of hPRL (PDB entry 1RW547) with the residues experiencing the largest 
chemical shift changes (>0.45 ppm) during the formation of the binary complex are marked. The sizes of the 
red spheres are proportional to the size of the observed chemical shift change.  
16D: The development of signal intensity of S26 during the hPRLR-ECD titration of hPRL (table 3). The blue 
bars represent the signal from S26, a residue in the HARBS, in unbound hPRL. The red bars represent S26 
in hPRL in the binary complex and the green bars represent G104, a residue not involved in hPRL-ECD 
binding. The intensities are normalized against the average of G104, S114 and K142, three residues not 
involved in hPRLR-ECD binding at either the HARBS or the LARBS on hPRL, and the error bars are derived 
from the S/N ratio. 
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Figure 17: Receptor binding at the LARBS on hPRL. 
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17A: Titration step 4 through 6 (table 3) in the hPRLR-ECD titration of hPRL monitored by 15N-HSQC at 
pH7, 35 °C, 600 MHz. The HSQC spectrum of the 1:1.33 hPRL:hPRLR-ECD concentration ratio is black, the 
1:1.66 spectrum is green and 1:2 spectrum is red. Residues G7, Q122 and G129 are part of the HARBS on 
hPRL, and the 1D traces show the development of peak intensity during the hPRLR-ECD titration. G104 is 
distal to both binding sites. 21 new signals appearing during step 5 and 6 in table 3 are highlighted. 
17B: The solution structure of hPRL (PDB entry 1RW547) with the residues chemical shift changes during 
the formation of the ternary hPRL:2hPRLR-ECD complex are marked. The red spheres represent residues 
in the LARBS on hPRL, while the blue spheres represent residues in or around the HARBS experiencing 
chemical shift changes during the formation of the ternary complex.  
17C: The development of the signal intensity of G129 during the hPRLR-ECD titration of hPRL (table 3). The 
blue bars represent the signal from G129, the central residue in the glycine binding pocket of the LARBS in 
unbound hPRL and hPRL in the binary complex. The green bars represent G104, a residue not involved in 
hPRL-ECD binding. The intensities are normalized against the average of G104, S114 and K142, three 
residues not involved in hPRLR-ECD binding at either the HARBS or the LARBS on hPRL, and the error 
bars are derived from the S/N ratio.  
17D: The development of signal intensity of Q122 during the hPRLR-ECD titration of hPRL (table 3). The 
blue bars represent the signal from G129, the central residue in the glycine binding pocket of the LARBS in 
unbound hPRL and hPRL in the binary complex. The red bars represent Q122 of hPRL in the ternary 
hPRL:2hPRLR-ECD complex, while the green bars represent G104, a residue not involved in hPRL-ECD 
binding. The intensities are normalized against the average of G104, S114 and K142, three residues not 
involved in hPRLR-ECD binding at either the HARBS or the LARBS on hPRL, and the error bars are derived 
from the S/N ratio. 
 
 
91 
 
-0.4 
-0.2 
0 
0.2 
0.4 
0 25 50 75 100 125 150 175 200 
Δ
S2
 
hPRL residue nr. 
0.0 
0.2 
0.4 
0.6 
0.8 
1.0 
1.2 
1.4 
0 25 50 75 100 125 150 175 200 
R
1 (
se
c-
1 )
 
hPRL in binary complex 
0.5 
0.7 
0.9 
1.1 
1.3 
1.5 
1.7 
0 25 50 75 100 125 150 175 200 
R
1 (
se
c-
1 )
 
unbound hPRL  
5 
15 
25 
35 
45 
0 25 50 75 100 125 150 175 200 
R
2 (
se
c-
1 )
 
10 
20 
30 
40 
50 
60 
0 25 50 75 100 125 150 175 200 
R
2 (
se
c-
1 )
 
0.0 
0.2 
0.4 
0.6 
0.8 
1.0 
0 25 50 75 100 125 150 175 200 
N
O
E 
0.0 
0.2 
0.4 
0.6 
0.8 
1.0 
0 25 50 75 100 125 150 175 200 
N
O
E 
0.2 
0.4 
0.6 
0.8 
1 
1.2 
0 25 50 75 100 125 150 175 200 
S2
 
0.2 
0.4 
0.6 
0.8 
1 
1.2 
0 25 50 75 100 125 150 175 200 
S2
 
5 
7 
9 
11 
13 
15 
17 
19 
0 25 50 75 100 125 150 175 200 
τ m
 (n
s)
  
5 
15 
25 
35 
45 
0 25 50 75 100 125 150 175 200 
τ m
 (n
s)
 
A 
B 
C 
D 
E 
F 
G 
H 
I 
J 
K 
 
 
92 
Figure 18: Per residue recorded NMR relaxation parameters and calculated model-free parameters of 
unbound hPRL and hPRL in the binary hPRL:hPRLR-ECD complex.  
18A-C: Recorded per residue NMR relaxation parameters (R1, R2 and NOE) for unbound hPRL at pH 7, 35 
°C, 600 MHz. Errors are calculated as described, but are not allowed to be less than 3% for R1 and R2 and 
0.05 for NOE. Green boxes represent the four α-helices. 
18D: Per residue overall correlation time of unbound hPRL estimated from R2/R1 ratios. Green boxes 
represent the four α-helices.  
18E: Per residue generalized order parameter of unbound hPRL calculated using DASHA24. Green boxes 
represent the four α-helices.  
18F-H: Recorded per residue NMR relaxation parameters (R1, R2 and NOE) for hPRL in the binary 
hPRL:hPRLR-ECD complex at pH 7, 35 °C, 600 MHz. Errors are calculated as described, but are not 
allowed to be less than 3% for R1 and R2 and 0.05 for NOE. Green boxes represent the four α-helices. 
18I: Per residue overall correlation time of hPRL in the binary hPRL:hPRLR-ECD complex estimated from 
R2/R1 ratios. Green boxes represent the four α-helices. 
18J: Per residue generalized order parameter of hPRL in the binary hPRL:hPRLR-ECD complex calculated 
using DASHA24. Green boxes represent the four α-helices. 
18K: The per residue change of the generalized order parameter (ΔS2) for hPRL during the formation of the 
binary hPRL:hPRLR-ECD complex. ΔS2 are represented as: S2COMPLEX - S2UNBOUND. Green boxes represent 
the four α-helices. 
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Figure 19: Crystal structure of hGH (PDB entry 1HGU)104. The H18, H21, E174 MBS is colored red. 
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Figure 20: Crystal structure of hGH (green) in binary complex with one hPRLR-ECD (yellow) (PDB entry 
1BP3)89. Coordination of Zn2+ (grey) between H18 and E174 (red) on hGH and D187R and H188R (red) on 
hPRLR-ECD enhances the binding affinity 8000-fold. 
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Figure 21: Architechture of the MBS proposed in hPRL by Sadineni et al.90, consisting of H27, H30 and 
H173 (colored in red). 
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Figure 22: Per residue PREs for hPRL observed in a 0.5:1 Cu2+:hPRL sample at 600 MHz, 35 °C, pH 7.0. 
The PREs are calculated by subtracting the R1 rates of hPRL from the R1 rates recorded for hPRL in the 
metal containing sample. 
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Figure 23: Line broadening of H180 during Cu2+ titration. 15N-HSQC spectra at 600 MHz, 35 °C, pH 7.0 of 
200 µM hPRL during multiple Cu2+ titration steps are shown superimposed with a 1-D trace on the edge. 
The shown titration steps are Cu2+:hPRL ratios of 0:1 (black), 0.5:1 (blue), 1:1 (red) and 2:1 (green) 
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Figure 24: Per residue PREs for hPRL observed in a 4:1 Cu2+:hPRL sample at 600 MHz, 35 °C, pH 7.0. The 
PREs are calculated by subtracting the R1 rates of hPRL from the R1 rates recorded for hPRL in the metal 
containing sample. 
 
  
 0
 1
 2
 3
 4
 5
 6
 7
 0  20  40  60  80  100  120  140  160  180  200
Helix 1 Helix 2 Helix 3 Helix 4
-
1
PR
E 
(s
)
Residue
 
 
99 
 
Figure 25: The two MBSs on hPRL. 25A: First cluster of residues in hPRL affected by metal-mediated PRE, 
the red represents the residues thought to be directly involved in metal coordination: H27, H30 and H180. 
The orange represents residues affected by PRE, but not directly involved in metal coordination: N31, S34, 
R177 and D183. 25B: Second cluster of residues in hPRL affected by metal-mediated PRE, the red 
represents the residue thought to be directly involved in metal coordination: E93 and H97. The orange 
represents residues affected by PRE, but directly involved in metal coordination: Y96, E101 and W150. 
Highly affected residues (red) and slightly affected residues (orange). 25C: Secondary structure 
representation of the H27, H30, H180 MBS on hPRL. 25D: Secondary structure representation of the 
E93,H97 MBS on hPRL. 
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Figure 26: Architechture of the proposed MBS, H27, H30 and H180 (colored red) on hPRL (PDB entry 
1RW5)47. The distance between the imidazole rings is shown. 
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Figure 27: 27A: The position of the H27, H30, H180 MBS compared to the position of the E93, H97 MBS on 
hPRL. The MBSs are colored red. 27B: Proposed model for metal-mediated aggregation in hPRL. The 
proposed availability of two metal coordination sites on opposite sides of hPRL will result in large, 
amorphous metal-mediated aggregates. 27C: Position of the MBS on hGH and the four glutamic acids that 
possibly act as coordinating residues for intramolecular metal bridging. The MBS and the potential metal 
coordinating site are colored red. 27D: Depicts a possible mechanism for the metal-mediated dimerization of 
hGH. 
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Figure 28: Per residue PREs for hPRL observed in 4:1 Cu2+:hPRL sample at 600 MHz, 35 °C, pH 7.0. The 
red curve is a 100 µM hPRL, 400 µM Cu2+ sample, and the blue curve is a 50 µM hPRL, 200 µM Cu2+ 
sample. The PREs are calculated by subtracting the R1 rates of hPRL from the R1 rates recorded for hPRL 
in the metal containing sample. 
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Figure 29: Per residue PREs for hPRL observed in 4:1 Cu2+:hPRL sample at 600 MHz, 35 °C, pH 7.0 with 
an excess of EDTA added. Cu2+ concentration is 400 µM and the EDTA concentration is 800 µM. The PREs 
are calculated by subtracting the R1 rates of hPRL from the R1 rates recorded for hPRL in the metal 
containing sample. 
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Figure 30: Per residue PREs for hPRL observed in the sample from figure 37 at 600 MHz, 35 °C, pH 7.0 
after it was cleaned on a size exclusion column. The PREs are calculated by subtracting the R1 rates of 
hPRL from the R1 rates recorded for hPRL in the metal containing sample. 
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Figure 31: Per residue PREs observed in a 0.3:1 Cu2+:hPRL sample at 600 MHz, 35 °C, pH 5.5. The PREs 
are calculated by subtracting the R1 rates of hPRL from the R1 rates recorded for hPRL in the metal 
containing sample. 
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Figure 32: Study of metal-induced protein aggregation using A280. 32A: Aggregation study of 25 μM wild 
type hPRL (red), H97A hPRL (green) and (H27A, H30A, H180A)hPRL (blue) at pH 7.0 (table 6). 32B: 
Aggregation study of 25 μM wild type hPRL (red), H97A hPRL (green) and (H27A, H30A, H180A)hPRL 
(blue) at pH 5.5 (table 7).  
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Figure 33: 33A: The position of the Cu2+ ion (green) at the H27, H30, H180 (red) MBS on hPRL estimated 
from PREs measured at pH 5.5 and fitted to the solution structures (20) of hPRL47 by least square 
minimization (MoSART) 33B: The position of the Cu2+ ion (green) at the E93, H97 (red) MBS on hPRL 
estimated from PREs measured at pH 5.5 and fitted to the solution structures (16) of hPRL47 by least square 
minimization (MoSART) 
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7 Tables 
Table 1: Models for the correlation functions (Cm(t) and Ce(t)) describing the overall and 
internal motions of molecules 
Model Type Model parameters Description 
1 Ce(t) 𝑆! Fast internal dynamics 
2 Ce(t) 𝑆!,𝑅!" Fast internal dynamics and chemical 
exchange 
3 Ce(t) 𝑆!, 𝜏! Picosecond internal dynamics 
4 Ce(t) 𝑆!, 𝜏! ,𝑅!" Picosecond internal dynamics and 
chemical exchange 
5 Ce(t) 𝑆!!, 𝑆!!, 𝜏! Fast and slow (≤ nanosecond) internal 
dynamics 
6 Cm(t) 𝜏! Isotropic overall tumbling  
7 Cm(t) 𝜏! ,𝐷∥ 𝐷! ,𝛼,𝛽 Tumbling of axially symmetric 
anisotropic molecule 
8 Cm(t) 𝜏! ,𝐷! 𝐷! ,𝐷! 𝐷! ,𝛼,𝛽, 𝛾 Tumbling of asymmetric anisotropic 
molecule 
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Table 2: Samples used in the FPLC study of hPRL:hPRLR-ECD complex formation  
Sample hPRL (µM) hPRLR-ECD (µM) Ratio 
1 12 12 1:1 
2 6 12 1:2 
3 3 12 1:4 
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Table 3: Steps in the hPRLR-ECD titration of hPRL monitored by 15N-HSQC. 
Titration step hPRL (µM) hPRLR-ECD (µM) Ratio 
0 200 0 1:0 
1 200 66 1:0.3 
2 200 132 1:0.7 
3 200 198 1:1 
4 200 264 1:1.3 
5 200 330 1:1.7 
6 200 400 1:2 
 
 
  
 
 
111 
 
Table 4: Per residue model-free parameters of unbound hPRL calculated from recorded 
NMR relaxation data at multiple field strenghts (500 and 800 MHz, pH 7, 35 °C) by 
DASHA24. Included are the generalized order parameter in two time scales (S2 and S2f), 
the internal motion correlation time τe and the contribution from chemical exchange Rex. 
The secondary structure elements of hPRL and model selection for the model-free 
analysis (from table 1) are also shown. 
Residue	   2°	   Model	   S2	   S2f	   τe	  (ns)	   Rex	  (s-­‐1)	  
I3	   	   5	   0.432	  ±	  0.0189	   0.752	  ±	  0.0228	   1.25	  ±	  0.1	   	  
G7	   	   5	   0.458	  ±	  0.0084	   0.746	  ±	  0.0087	   1.246	  ±	  0.035	   	  
R10	   	   5	   0.629	  ±	  0.0051	   0.808	  ±	  0.0058	   1.641	  ±	  0.059	   	  
V13	   	   5	   0.784	  ±	  0.0082	   0.796	  ±	  0.0092	   1.498	  ±	  0.131	   	  
L15	   α1	   1	   0.947	  ±	  0.0157	   	   	   	  
R16	   α1	   1	   0.973	  ±	  0.0265	   	   	   	  
D17	   α1	   1	   0.946	  ±	  0.0112	   	   	   	  
L18	   α1	   1	   0.935	  ±	  0.0071	   	   	   	  
F19	   α1	   1	   0.953	  ±	  0.0098	   	   	   	  
D20	   α1	   1	   0.918	  ±	  0.0088	   	   	   	  
A22	   α1	   1	   0.934	  ±	  0.0154	   	   	   	  
V23	   α1	   2	   0.918	  ±	  0.0068	   	   	   1.05	  ±	  0.12	  
V24	   α1	   2	   0.917	  ±	  0.011	   	   	   0.97	  ±	  0.2	  
L25	   α1	   1	   0.973	  ±	  0.0159	   	   	   	  
S26	   α1	   2	   0.923	  ±	  0.0138	   	   	   1.15	  ±	  0.25	  
H27	   α1	   2	   0.964	  ±	  0.0201	   	   	   1.01	  ±	  0.36	  
Y28	   α1	   1	   0.928	  ±	  0.0164	   	   	   	  
I29	   α1	   1	   0.945	  ±	  0.0113	   	   	   	  
H30	   α1	   1	   0.966	  ±	  0.0172	   	   	   	  
N31	   α1	   1	   0.955	  ±	  0.023	   	   	   	  
S33	   α1	   2	   0.927	  ±	  0.0072	   	   	   0.95	  ±	  0.13	  
S34	   α1	   1	   0.959	  ±	  0.0121	   	   	   	  
M36	   α1	   1	   0.943	  ±	  0.011	   	   	   	  
F37	   α1	   1	   0.943	  ±	  0.015	   	   	   	  
S38	   α1	   1	   0.925	  ±	  0.0105	   	   	   	  
E39	   α1	   1	   0.945	  ±	  0.0131	   	   	   	  
F40	   α1	   1	   0.936	  ±	  0.0149	   	   	   	  
D41	   α1	   1	   0.965	  ±	  0.0115	   	   	   	  
K42	   α1	   1	   0.919	  ±	  0.0069	   	   	   	  
R43	   α1	   2	   0.904	  ±	  0.0232	   	   	   0.94	  ±	  0.4	  
Y44	   	   2	   0.903	  ±	  0.0149	   	   	   1.15	  ±	  0.27	  
T45	   	   3	   0.949	  ±	  0.0113	   	   0.931	  ±	  0.288	   	  
H46	   	   4	   0.931	  ±	  0.0111	   	   1.033	  ±	  0.209	   0.61	  ±	  0.2	  
F50	   	   5	   0.894	  ±	  0.0114	   0.923	  ±	  0.0151	   1.135	  ±	  0.227	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Residue	   2°	   Model	   S2	   S2f	   τe	  (ns)	   Rex	  (s-­‐1)	  
I51	   	   5	   0.812	  ±	  0.0016	   0.864	  ±	  0.0019	   2.016	  ±	  0.052	   	  
T52	   	   3	   0.807	  ±	  0.0351	   	   1.097	  ±	  0.283	   	  
I55	   	   5	   0.751	  ±	  0.011	   0.828	  ±	  0.0127	   1.581	  ±	  0.171	   	  
T60	   α1’	   4	   0.954	  ±	  0.0215	   	   1.056	  ±	  0.61	   1.72	  ±	  0.44	  
S61	   α1’	   3	   0.951	  ±	  0.0128	   	   0.837	  ±	  0.302	   	  
L63	   	   5	   0.924	  ±	  0.0068	   0.911	  ±	  0.0098	   1.751	  ±	  0.434	   	  
A64	   	   5	   0.851	  ±	  0.0105	   0.829	  ±	  0.0124	   1.224	  ±	  0.168	   	  
T65	   	   5	   0.752	  ±	  0.0092	   0.71	  ±	  0.0095	   1.451	  ±	  0.12	   	  
E67	   	   5	   0.83	  ±	  0.0094	   0.89	  ±	  0.011	   1.031	  ±	  0.092	   	  
D68	   	   5	   0.798	  ±	  0.0268	   0.884	  ±	  0.0338	   1.149	  ±	  0.285	   	  
E70	   α1’’	   5	   0.817	  ±	  0.0035	   0.859	  ±	  0.0044	   1.245	  ±	  0.047	   	  
Q71	   α1’’	   5	   0.833	  ±	  0.0052	   0.872	  ±	  0.0067	   1.201	  ±	  0.071	   	  
A72	   α1’’	   5	   0.813	  ±	  0.0059	   0.888	  ±	  0.0076	   1.721	  ±	  0.142	   	  
Q73	   α1’’	   5	   0.88	  ±	  0.0101	   0.92	  ±	  0.0137	   1.245	  ±	  0.204	   	  
Q74	   α1’’	   3	   0.914	  ±	  0.0192	   	   0.63	  ±	  0.216	   	  
M75	   	   5	   0.811	  ±	  0.0115	   0.843	  ±	  0.014	   1.791	  ±	  0.295	   	  
N76	   	   3	   0.881	  ±	  0.026	   	   0.79	  ±	  0.247	   	  
K78	   α2	   5	   0.916	  ±	  0.0026	   0.927	  ±	  0.0038	   1.613	  ±	  0.128	   	  
D79	   α2	   5	   0.94	  ±	  0.0025	   0.935	  ±	  0.0037	   2.195	  ±	  0.304	   	  
F80	   α2	   5	   0.898	  ±	  0.0045	   0.889	  ±	  0.0062	   1.623	  ±	  0.179	   	  
L81	   α2	   1	   0.91	  ±	  0.0103	   	   	   	  
S82	   α2	   1	   0.897	  ±	  0.0148	   	   	   	  
L83	   α2	   1	   0.937	  ±	  0.0114	   	   	   	  
S86	   α2	   1	   0.968	  ±	  0.012	   	   	   	  
I87	   α2	   1	   0.94	  ±	  0.0174	   	   	   	  
L88	   α2	   1	   0.943	  ±	  0.0092	   	   	   	  
R89	   α2	   1	   0.943	  ±	  0.0075	   	   	   	  
S90	   α2	   1	   0.951	  ±	  0.0109	   	   	   	  
W91	   α2	   1	   0.937	  ±	  0.0095	   	   	   	  
N92	   α2	   1	   0.936	  ±	  0.0126	   	   	   	  
E93	   α2	   1	   0.942	  ±	  0.0188	   	   	   	  
L95	   α2	   1	   0.925	  ±	  0.0077	   	   	   	  
Y96	   α2	   2	   0.947	  ±	  0.0175	   	   	   	  
H97	   α2	   2	   0.935	  ±	  0.0077	   	   	   1.46	  ±	  0.13	  
L98	   α2	   1	   0.915	  ±	  0.0068	   	   	   1.13	  ±	  0.12	  
V99	   α2	   1	   0.95	  ±	  0.0098	   	   	   	  
T100	   α2	   1	   0.953	  ±	  0.0165	   	   	   	  
E101	   α2	   1	   0.96	  ±	  0.0162	   	   	   	  
R103	   α2	   1	   0.977	  ±	  0.0164	   	   	   	  
G104	   	   1	   0.913	  ±	  0.0289	   	   	   	  
M105	   	   5	   0.942	  ±	  0.0079	   0.901	  ±	  0.0113	   1.159	  ±	  0.298	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Residue	   2°	   Model	   S2	   S2f	   τe	  (ns)	   Rex	  (s-­‐1)	  
Q106	   	   5	   0.803	  ±	  0.0029	   0.845	  ±	  0.0033	   0.898	  ±	  0.021	   	  
E107	   	   5	   0.798	  ±	  0.009	   0.852	  ±	  0.0107	   1.03	  ±	  0.081	   	  
A108	   	   5	   0.666	  ±	  0.0167	   0.784	  ±	  0.0181	   1.041	  ±	  0.095	   	  
I112	   α3	   5	   0.9	  ±	  0.0025	   0.879	  ±	  0.0034	   1.134	  ±	  0.052	   	  
L113	   α3	   3	   0.898	  ±	  0.0094	   	   0.071	  ±	  0.014	   	  
S114	   α3	   1	   0.919	  ±	  0.0238	   	   	   	  
K115	   α3	   1	   0.927	  ±	  0.0114	   	   	   	  
V117	   α3	   1	   0.929	  ±	  0.0072	   	   	   	  
E118	   α3	   1	   0.952	  ±	  0.0082	   	   	   	  
I119	   α3	   1	   0.947	  ±	  0.0096	   	   	   	  
E120	   α3	   1	   0.955	  ±	  0.0092	   	   	   	  
E121	   α3	   1	   0.927	  ±	  0.01	   	   	   	  
Q122	   α3	   2	   0.907	  ±	  0.012	   	   	   0.82	  ±	  0.21	  
K124	   α3	   1	   0.924	  ±	  0.0029	   	   	   	  
L126	   α3	   1	   0.935	  ±	  0.0114	   	   	   	  
L127	   α3	   1	   0.939	  ±	  0.0091	   	   	   	  
E128	   α3	   1	   0.924	  ±	  0.0053	   	   	   	  
G129	   α3	   1	   0.912	  ±	  0.0106	   	   	   	  
M130	   α3	   1	   0.955	  ±	  0.0077	   	   	   	  
E131	   α3	   1	   0.934	  ±	  0.0031	   	   	   	  
L132	   α3	   1	   0.942	  ±	  0.0094	   	   	   	  
V134	   α3	   1	   0.96	  ±	  0.0063	   	   	   	  
S135	   α3	   1	   0.922	  ±	  0.0138	   	   	   	  
Q136	   α3	   1	   0.936	  ±	  0.013	   	   	   	  
V137	   α3	   1	   0.909	  ±	  0.0209	   	   	   	  
H138	   	   3	   0.913	  ±	  0.0193	   	   0.112	  ±	  0.042	   	  
E140	   	   5	   0.767	  ±	  0.006	   0.847	  ±	  0.0068	   1.919	  ±	  0.138	   	  
T141	   	   5	   0.737	  ±	  0.0144	   0.837	  ±	  0.0169	   1.678	  ±	  0.237	   	  
K142	   	   5	   0.611	  ±	  0.0148	   0.81	  ±	  0.0169	   1.268	  ±	  0.1	   	  
E143	   	   5	   0.626	  ±	  0.0125	   0.77	  ±	  0.0135	   1.519	  ±	  0.124	   	  
N144	   	   5	   0.525	  ±	  0.0213	   0.769	  ±	  0.0245	   1.398	  ±	  0.151	   	  
E145	   	   5	   0.512	  ±	  0.0164	   0.729	  ±	  0.0179	   1.441	  ±	  0.122	   	  
I146	   	   5	   0.587	  ±	  0.0154	   0.729	  ±	  0.0162	   1.73	  ±	  0.184	   	  
Y147	   	   5	   0.792	  ±	  0.0196	   0.887	  ±	  0.0243	   1.26	  ±	  0.236	   	  
V149	   	   5	   0.874	  ±	  0.0129	   0.838	  ±	  0.0153	   0.998	  ±	  0.178	   	  
W150	   	   3	   0.805	  ±	  0.0374	   	   0.1	  ±	  0.037	   	  
M158	   	   5	   0.848	  ±	  0.0085	   0.886	  ±	  0.0113	   1.461	  ±	  0.183	   	  
A159	   	   5	   0.84	  ±	  0.0069	   0.811	  ±	  0.0034	   4.057	  ±	  0.442	   	  
E161	   α4	   4	   0.9	  ±	  0.0327	   	   0.045	  ±	  0.026	   5.21	  ±	  0.57	  
E162	   α4	   1	   0.979	  ±	  0.033	   	   	   	  
S163	   α4	   1	   0.95	  ±	  0.0255	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Residue	   2°	   Model	   S2	   S2f	   τe	  (ns)	   Rex	  (s-­‐1)	  
R164	   α4	   1	   0.973	  ±	  0.0203	   	   	   	  
L165	   α4	   1	   0.974	  ±	  0.0184	   	   	   	  
A167	   α4	   1	   0.97	  ±	  0.018	   	   	   	  
Y168	   α4	   2	   0.909	  ±	  0.0112	   	   	   1.05	  ±	  0.2	  
Y169	   α4	   2	   0.908	  ±	  0.0087	   	   	   0.93	  ±	  0.16	  
N170	   α4	   1	   0.943	  ±	  0.015	   	   	   	  
L171	   α4	   2	   0.903	  ±	  0.0085	   	   	   0.91	  ±	  0.15	  
L172	   α4	   2	   0.918	  ±	  0.0129	   	   	   1.03	  ±	  0.23	  
H173	   α4	   1	   1	  ±	  0.0008	   	   	   	  
C174	   α4	   1	   0.982	  ±	  0.0142	   	   	   	  
L175	   α4	   1	   0.962	  ±	  0.016	   	   	   	  
R176	   α4	   1	   0.955	  ±	  0.0082	   	   	   	  
R177	   α4	   3	   0.935	  ±	  0.0191	   	   0.085	  ±	  0.043	   	  
D178	   α4	   1	   0.935	  ±	  0.0108	   	   	   	  
S179	   α4	   2	   0.941	  ±	  0.0178	   	   	   0.8	  ±	  0.32	  
H180	   α4	   2	   0.956	  ±	  0.0167	   	   	   1.02	  ±	  0.3	  
K181	   α4	   1	   0.928	  ±	  0.0116	   	   	   	  
I182	   α4	   1	   0.924	  ±	  0.013	   	   	   	  
D183	   α4	   1	   0.956	  ±	  0.0134	   	   	   	  
N184	   α4	   1	   0.935	  ±	  0.0159	   	   	   	  
Y185	   α4	   1	   0.936	  ±	  0.0071	   	   	   	  
L186	   α4	   1	   0.97	  ±	  0.0145	   	   	   	  
K187	   α4	   1	   0.926	  ±	  0.0149	   	   	   	  
L189	   α4	   1	   0.97	  ±	  0.0075	   	   	   	  
C191	   α4	   1	   0.97	  ±	  0.0172	   	   	   	  
R192	   α4	   1	   0.945	  ±	  0.016	   	   	   	  
I193	   α4	   2	   0.895	  ±	  0.0143	   	   	   0.91	  ±	  0.25	  
I194	   	   3	   0.917	  ±	  0.0175	   	   0.053	  ±	  0.029	   	  
N198	   	   5	   0.865	  ±	  0.0154	   0.898	  ±	  0.0204	   1.754	  ±	  0.538	   	  
C199	   	   5	   0.693	  ±	  0.0144	   0.704	  ±	  0.0139	   1.195	  ±	  0.109	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Tabel 5: Per residue model-free parameters of hPRL in the binary hPRL:hPRLR-ECD 
complex calculated from recorded NMR relaxation data at multiple field strenghts (600 
and 800 MHz, pH 7, 35 °C) by DASHA24. Included are the generalized order parameter 
in two time scales (S2 and S2f), the internal motion correlation time τe and the contribution 
from chemical exchange Rex. The secondary structure elements of hPRL and model 
selection for the model-free analysis (from table 1) are also shown. 
Residue	   2°	   Model	   S2	   S2f	   τe	  (ns)	   Rex	  (s-­‐1)	  
I3	   	   5	   0.474	  ±	  0.0342	   0.658	  ±	  0.0415	   1.18	  ±	  0.189	   	  
C4	   	   3	   0.421	  ±	  0.0641	   	   0.92	  ±	  0.159	   	  
G7	   	   5	   0.396	  ±	  0.0431	   0.728	  ±	  0.061	   1.42	  ±	  0.327	   	  
R10	   	   5	   0.494	  ±	  0.0349	   0.67	  ±	  0.0406	   1.47	  ±	  0.27	   	  
T14	   	   5	   0.805	  ±	  0.0154	   0.813	  ±	  0.0221	   1.06	  ±	  0.104	   	  
L15	   α1	   1	   0.91	  ±	  0.072	   	   	   	  
R16	   α1	   3	   0.937	  ±	  0.0387	   	   0.07	  ±	  0.058	   	  
L18	   α1	   1	   0.895	  ±	  0.0219	   	   	   	  
F19	   α1	   1	   0.991	  ±	  0.0697	   	   	   	  
D20	   α1	   3	   0.942	  ±	  0.0573	   	   0.08	  ±	  0.099	   	  
V24	   α1	   3	   0.963	  ±	  0.0399	   	   0.26	  ±	  2.375	   	  
L25	   α1	   1	   0.912	  ±	  0.0713	   	   	   	  
S26	   α1	   1	   0.902	  ±	  0.0517	   	   	   	  
H27	   α1	   1	   0.93	  ±	  0.02	   	   	   	  
Y28	   α1	   1	   0.965	  ±	  0.1017	   	   	   	  
I29	   α1	   1	   0.926	  ±	  0.0491	   	   	   	  
H30	   α1	   3	   0.918	  ±	  0.0227	   	   0.05	  ±	  0.021	   	  
N31	   α1	   1	   0.97	  ±	  0.0802	   	   	   	  
L32	   α1	   1	   0.976	  ±	  0.0888	   	   	   	  
S33	   α1	   1	   0.941	  ±	  0.0507	   	   	   	  
S34	   α1	   3	   0.916	  ±	  0.0359	   	   0.05	  ±	  0.028	   	  
E35	   α1	   1	   0.861	  ±	  0.0684	   	   	   	  
M36	   α1	   1	   0.897	  ±	  0.0752	   	   	   	  
F37	   α1	   3	   0.838	  ±	  0.0481	   	   0.04	  ±	  0.019	   	  
S38	   α1	   3	   0.858	  ±	  0.0301	   	   0.03	  ±	  0.014	   	  
E39	   α1	   3	   0.884	  ±	  0.0199	   	   0.05	  ±	  0.014	   	  
F40	   α1	   3	   0.947	  ±	  0.045	   	   0.14	  ±	  0.172	   	  
K42	   α1	   1	   0.905	  ±	  0.0617	   	   	   	  
R43	   α1	   3	   0.947	  ±	  0.0542	   	   0.12	  ±	  0.204	   	  
Y44	   	   1	   0.908	  ±	  0.0757	   	   	   	  
I51	   	   3	   0.932	  ±	  0.0272	   	   0.13	  ±	  0.068	   	  
T52	   	   3	   0.899	  ±	  0.0213	   	   0.03	  ±	  0.01	   	  
K53	   	   3	   0.915	  ±	  0.0291	   	   0.1	  ±	  0.053	   	  
A54	   	   3	   0.925	  ±	  0.0441	   	   0.11	  ±	  0.093	   	  
I55	   	   5	   0.893	  ±	  0.0131	   0.88	  ±	  0.0237	   1.05	  ±	  0.148	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Residue	   2°	   Model	   S2	   S2f	   τe	  (ns)	   Rex	  (s-­‐1)	  
N56	   	   3	   0.792	  ±	  0.0133	   	   0.02	  ±	  0.003	   	  
S57	   	   1	   0.874	  ±	  0.0377	   	   	   	  
L63	   	   1	   0.836	  ±	  0.0424	   	   	   	  
A64	   	   5	   0.907	  ±	  0.0122	   0.796	  ±	  0.0257	   0.55	  ±	  0.107	   	  
T65	   	   3	   0.712	  ±	  0.0275	   	   0.04	  ±	  0.007	   	  
E67	   	   3	   0.8	  ±	  0.0302	   	   0.03	  ±	  0.009	   	  
D68	   	   1	   0.91	  ±	  0.0461	   	   	   	  
K69	   α1’’	   3	   0.883	  ±	  0.0517	   	   0.05	  ±	  0.036	   	  
E70	   α1’’	   3	   0.957	  ±	  0.0339	   	   0.11	  ±	  0.123	   	  
Q71	   α1’’	   3	   0.97	  ±	  0.0436	   	   0.21	  ±	  0.941	   	  
A72	   α1’’	   1	   0.899	  ±	  0.0325	   	   	   	  
Q73	   α1’’	   1	   0.927	  ±	  0.082	   	   	   	  
Q74	   α1’’	   1	   0.864	  ±	  0.0594	   	   	   	  
M75	   	   1	   0.787	  ±	  0.0603	   	   	   	  
N76	   	   3	   0.851	  ±	  0.0112	   	   0.05	  ±	  0.006	   	  
D79	   α2	   1	   0.854	  ±	  0.0533	   	   	   	  
F80	   α2	   1	   0.836	  ±	  0.0217	   	   	   	  
L81	   α2	   1	   0.904	  ±	  0.071	   	   	   	  
S82	   α2	   3	   0.883	  ±	  0.03	   	   0.03	  ±	  0.016	   	  
I84	   α2	   1	   0.858	  ±	  0.0431	   	   	   	  
S86	   α2	   3	   0.945	  ±	  0.0354	   	   0.11	  ±	  0.1	   	  
I87	   α2	   3	   0.881	  ±	  0.0695	   	   0.05	  ±	  0.038	   	  
L88	   α2	   1	   0.959	  ±	  0.0654	   	   	   	  
S90	   α2	   1	   0.882	  ±	  0.0567	   	   	   	  
W91	   α2	   1	   0.898	  ±	  0.0522	   	   	   	  
N92	   α2	   3	   0.803	  ±	  0.0116	   	   0.03	  ±	  0.004	   	  
E93	   α2	   5	   0.956	  ±	  0.0059	   0.857	  ±	  0.0143	   0.6	  ±	  0.123	   	  
L95	   α2	   1	   0.813	  ±	  0.0454	   	   	   	  
Y96	   α2	   1	   0.859	  ±	  0.0324	   	   	   	  
H97	   α2	   3	   0.98	  ±	  0.0411	   	   0.2	  ±	  0.976	   	  
L98	   α2	   1	   0.82	  ±	  0.0443	   	   	   	  
V99	   α2	   3	   0.869	  ±	  0.0387	   	   0.03	  ±	  0.016	   	  
T100	   α2	   3	   0.785	  ±	  0.0508	   	   0.04	  ±	  0.014	   	  
E101	   α2	   3	   0.875	  ±	  0.0251	   	   0.02	  ±	  0.011	   	  
V102	   α2	   3	   0.826	  ±	  0.0337	   	   0.03	  ±	  0.01	   	  
R103	   α2	   1	   0.978	  ±	  0.0442	   	   	   	  
G104	   	   5	   0.92	  ±	  0.0128	   0.79	  ±	  0.0322	   0.62	  ±	  0.133	   	  
M105	   	   3	   0.832	  ±	  0.0412	   	   0.05	  ±	  0.019	   	  
Q106	   	   5	   0.83	  ±	  0.0104	   0.77	  ±	  0.0116	   0.58	  ±	  0.037	   	  
E107	   	   5	   0.781	  ±	  0.0186	   0.763	  ±	  0.0213	   0.78	  ±	  0.067	   	  
A108	   	   5	   0.709	  ±	  0.0239	   0.737	  ±	  0.0317	   0.84	  ±	  0.095	   	  
 
 
117 
Residue	   2°	   Model	   S2	   S2f	   τe	  (ns)	   Rex	  (s-­‐1)	  
I112	   α3	   5	   0.906	  ±	  0.0236	   0.792	  ±	  0.0487	   0.73	  ±	  0.245	   	  
L113	   α3	   3	   0.829	  ±	  0.0431	   	   0.04	  ±	  0.018	   	  
S114	   α3	   3	   0.794	  ±	  0.0176	   	   0.03	  ±	  0.006	   	  
K115	   α3	   3	   0.95	  ±	  0.0325	   	   0.19	  ±	  0.337	   	  
A116	   α3	   1	   0.964	  ±	  0.0926	   	   	   	  
V117	   α3	   1	   0.907	  ±	  0.0444	   	   	   	  
E118	   α3	   1	   0.963	  ±	  0.0658	   	   	   	  
I119	   α3	   3	   0.823	  ±	  0.058	   	   0.03	  ±	  0.016	   	  
E120	   α3	   5	   0.962	  ±	  0.0046	   0.833	  ±	  0.0118	   0.5	  ±	  0.107	   	  
E121	   α3	   5	   0.977	  ±	  0.0046	   0.869	  ±	  0.0095	   0.89	  ±	  0.235	   	  
Q122	   α3	   1	   0.932	  ±	  0.0451	   	   	   	  
T123	   α3	   1	   0.925	  ±	  0.0366	   	   	   	  
K124	   α3	   3	   0.945	  ±	  0.0168	   	   0.53	  ±	  0.231	   	  
L126	   α3	   3	   0.8	  ±	  0.017	   	   0.02	  ±	  0.003	   	  
L127	   α3	   5	   0.965	  ±	  0.004	   0.863	  ±	  0.0078	   0.84	  ±	  0.123	   	  
E128	   α3	   1	   0.889	  ±	  0.0286	   	   	   	  
G129	   α3	   3	   0.801	  ±	  0.0416	   	   0.02	  ±	  0.01	   	  
L132	   α3	   1	   0.887	  ±	  0.0535	   	   	   	  
V134	   α3	   1	   0.907	  ±	  0.0509	   	   	   	  
S135	   α3	   1	   0.829	  ±	  0.0542	   	   	   	  
Q136	   α3	   3	   0.814	  ±	  0.0242	   	   0.03	  ±	  0.008	   	  
V137	   α3	   1	   0.865	  ±	  0.0472	   	   	   	  
H138	   	   3	   0.839	  ±	  0.0428	   	   0.05	  ±	  0.019	   	  
E140	   	   5	   0.802	  ±	  0.0162	   0.792	  ±	  0.0257	   1.52	  ±	  0.359	   	  
T141	   	   5	   0.741	  ±	  0.0239	   0.785	  ±	  0.0298	   1.22	  ±	  0.177	   	  
K142	   	   5	   0.588	  ±	  0.0419	   0.69	  ±	  0.0497	   1.24	  ±	  0.228	   	  
E143	   	   5	   0.724	  ±	  0.0308	   0.712	  ±	  0.0431	   1.22	  ±	  0.214	   	  
N144	   	   5	   0.677	  ±	  0.0403	   0.683	  ±	  0.0449	   1.28	  ±	  0.3	   	  
E145	   	   5	   0.426	  ±	  0.0503	   0.644	  ±	  0.0525	   1.19	  ±	  0.145	   	  
I146	   	   5	   0.567	  ±	  0.0376	   0.68	  ±	  0.044	   1.22	  ±	  0.247	   	  
Y147	   	   5	   0.748	  ±	  0.0233	   0.765	  ±	  0.0325	   0.97	  ±	  0.14	   	  
V149	   	   3	   0.763	  ±	  0.0328	   	   0.04	  ±	  0.01	   	  
W150	   	   5	   0.875	  ±	  0.0122	   0.813	  ±	  0.0225	   0.47	  ±	  0.077	   	  
Q157	   	   3	   0.871	  ±	  0.0379	   	   0.09	  ±	  0.036	   	  
M158	   	   3	   0.879	  ±	  0.0351	   	   0.09	  ±	  0.04	   	  
A159	   	   5	   0.911	  ±	  0.018	   0.753	  ±	  0.0233	   0.7	  ±	  0.16	   	  
D160	   	   5	   0.882	  ±	  0.0144	   0.747	  ±	  0.0245	   0.62	  ±	  0.105	   	  
E161	   α4	   3	   0.959	  ±	  0.025	   	   0.24	  ±	  0.731	   	  
E162	   α4	   3	   0.936	  ±	  0.0357	   	   0.14	  ±	  0.122	   	  
S163	   α4	   3	   0.855	  ±	  0.0352	   	   0.04	  ±	  0.016	   	  
R164	   α4	   3	   0.872	  ±	  0.0226	   	   0.04	  ±	  0.009	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Residue	   2°	   Model	   S2	   S2f	   τe	  (ns)	   Rex	  (s-­‐1)	  
L165	   α4	   1	   0.891	  ±	  0.0735	   	   	   	  
S166	   α4	   1	   0.878	  ±	  0.0422	   	   	   	  
Y168	   α4	   3	   0.931	  ±	  0.0512	   	   0.08	  ±	  0.081	   	  
Y169	   α4	   1	   0.913	  ±	  0.0411	   	   	   	  
L171	   α4	   1	   0.891	  ±	  0.0209	   	   	   	  
L172	   α4	   3	   0.978	  ±	  0.0518	   	   0.22	  ±	  1.984	   	  
H173	   α4	   3	   0.897	  ±	  0.0441	   	   0.04	  ±	  0.026	   	  
C174	   α4	   1	   0.896	  ±	  0.079	   	   	   	  
L175	   α4	   1	   0.922	  ±	  0.0587	   	   	   	  
R177	   α4	   3	   0.958	  ±	  0.036	   	   0.2	  ±	  0.456	   	  
D178	   α4	   3	   0.877	  ±	  0.0137	   	   0.03	  ±	  0.006	   	  
S179	   α4	   3	   0.984	  ±	  0.0133	   	   0.25	  ±	  0.877	   	  
H180	   α4	   3	   0.951	  ±	  0.0503	   	   0.13	  ±	  0.213	   	  
K181	   α4	   1	   0.886	  ±	  0.05	   	   	   	  
I182	   α4	   1	   0.855	  ±	  0.0519	   	   	   	  
D183	   α4	   1	   0.965	  ±	  0.0494	   	   	   	  
Y185	   α4	   1	   0.845	  ±	  0.0499	   	   	   	  
L186	   α4	   3	   0.932	  ±	  0.0334	   	   0.05	  ±	  0.041	   	  
K187	   α4	   3	   0.873	  ±	  0.0432	   	   0.03	  ±	  0.019	   	  
L188	   α4	   2	   0.799	  ±	  0.0163	   	   	   4.15	  ±	  0.78	  
K190	   α4	   1	   0.949	  ±	  0.0417	   	   	   	  
C191	   α4	   3	   0.956	  ±	  0.0437	   	   0.14	  ±	  0.243	   	  
R192	   α4	   3	   0.896	  ±	  0.0254	   	   0.03	  ±	  0.012	   	  
I193	   α4	   1	   0.969	  ±	  0.0775	   	   	   	  
I194	   	   1	   0.931	  ±	  0.0537	   	   	   	  
N196	   	   3	   0.849	  ±	  0.0371	   	   0.03	  ±	  0.014	   	  
N197	   	   1	   0.878	  ±	  0.0482	   	   	   	  
N198	   	   3	   0.853	  ±	  0.0464	   	   0.04	  ±	  0.023	   	  
C199	   	   3	   0.816	  ±	  0.0603	   	   0.05	  ±	  0.021	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Table 6: Zn2+ titration of hPRL variants (wild type, (H27A,H30A,H180A) and H97A) at pH 
7.0. 
Step hPRL variant concentration (µM) Zn2+ concentration (µM) Ratio 
0 25 0 1:0 
1 25 12.5 1:0.5 
2 25 25 1:1 
3 25 50 1:2 
4 25 100 1:4 
5 25 250 1:10 
6 25 500 1:20 
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Table 7: Zn2+ titration of hPRL variants (wild type, (H27A,H30A,H180A) and H97A) at pH 
5.5. 
Step hPRL variant concentration (µM) Zn2+ concentration (µM) Ratio 
0 25 0 1:0 
1 25 100 1:4 
2 25 500 1:20 
3 25 1000 1:40 
4 25 2000 1:80 
5 25 4000 1:160 
6 25 8000 1:320 
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Table 8: Distance restraints used in the estimation of the Cu2+ ion position in the two 
MBSs on hPRL by least square minimization (MoSART). The distance restraint is 
between the metal ion and the nitrogen of the backbone amide. 
H27, H30, H180 MBS 
residue 
distance restraint 
(Å) 
E93, H97 MBS 
residue 
distance restraint 
(Å) 
H27 5.5 – 7.5 E93 5.2 – 7.2 
Y28 5.7 – 7.7 Y96 5.7 – 7.7 
H30 5.7 – 7.7 H97 5.1 – 7.1 
N31 5.5 – 7.5 L98 6.0 – 8.0 
S34 5.6 – 7.6 E101 5.6 – 7.6 
R177 5.3 – 7.3   
D178 5.6 – 7.6   
S179 5.4 – 7.4   
H180 5.0 – 7.0   
D183 5.3 – 7.3   
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